Unnamed: 0,action_type,activity_comment,activity_id,activity_properties,assay_chembl_id,assay_description,assay_type,assay_variant_accession,assay_variant_mutation,bao_endpoint,bao_format,bao_label,canonical_smiles,data_validity_comment,data_validity_description,document_chembl_id,document_journal,document_year,ligand_efficiency,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,pchembl_value,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_text_value,standard_type,standard_units,standard_upper_value,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,text_value,toid,type,units,uo_units,upper_value,value
113000,,,5151207,[],CHEMBL1655914,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 9 preincubated with 0.1 ug/ml erythromycin for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113001,,,5151208,[],CHEMBL1655915,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 14 preincubated with 0.1 ug/ml erythromycin for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113002,,,5151209,[],CHEMBL1655916,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 14 preincubated with 0.1 ug/ml erythromycin for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113003,,,5151210,[],CHEMBL1655917,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 3 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113004,,,5151211,[],CHEMBL1655918,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 3 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113005,,,5151212,[],CHEMBL1655919,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 5 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113006,,,5151213,[],CHEMBL1655920,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 5 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113007,,,5151214,[],CHEMBL1655921,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 7 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113008,,,5151215,[],CHEMBL1655922,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 7 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113009,,,5151216,[],CHEMBL1655923,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 9 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113010,,,5151217,[],CHEMBL1655924,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 9 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113011,,,5151218,[],CHEMBL1655925,Antimicrobial activity against Mycobacterium abscessus isolate MC879-2 at day 14 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113012,,,5151219,[],CHEMBL1655926,Antimicrobial activity against Mycobacterium abscessus isolate MC1448 at day 14 preincubated with 0.1 ug/ml for 3 days by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113013,,,5151238,[],CHEMBL1655927,Antimicrobial activity against Mycobacterium abscessus isolate MC879 on day 4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,2.0
113014,,,5151239,[],CHEMBL1655928,Antimicrobial activity against Mycobacterium abscessus isolate MC958 on day 4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,2.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,2.0
113015,,,5151240,[],CHEMBL1655930,Antimicrobial activity against Mycobacterium abscessus isolate MC879 on day 10 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113016,,,5151241,[],CHEMBL1655931,Antimicrobial activity against Mycobacterium abscessus isolate MC958 on day 10 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113017,,,5151242,[],CHEMBL1655932,Antimicrobial activity against Mycobacterium abscessus isolate MC879 on day 14 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113018,,,5151243,[],CHEMBL1655933,Antimicrobial activity against Mycobacterium abscessus isolate MC958 on day 14 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,,MIC,ug ml-1,UO_0000274,,32.0
113019,,,5151245,[],CHEMBL1655934,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC879 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
113020,,,5151250,[],CHEMBL1655935,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC958 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
113021,,,5151255,[],CHEMBL1655936,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC719 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
113022,,,5151260,[],CHEMBL1656060,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC720 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
113023,,,5151265,[],CHEMBL1656061,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC879 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,16.0
113024,,,5151270,[],CHEMBL1656062,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC958 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,16.0
113025,,,5151275,[],CHEMBL1656063,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC719 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,16.0
113026,,,5151280,[],CHEMBL1656064,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC720 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,16.0
113027,,,5151285,[],CHEMBL1656065,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC879-2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,2.0
113028,,,5151290,[],CHEMBL1656066,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC879-2 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,16.0
113029,,,5151295,[],CHEMBL1656067,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MAB30 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113030,,,5151300,[],CHEMBL1656068,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC1028 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113031,,,5151305,[],CHEMBL1656069,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC1082 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113032,,,5151310,[],CHEMBL1656070,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MAB30 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113033,,,5151315,[],CHEMBL1656071,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC1028 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113034,,,5151320,[],CHEMBL1656072,Antimicrobial activity against Mycobacterium smegmatis transformed with erm allele Mycobacterium abscessus isolate MC1082 preincubated with 2 ug/ml erythromycin for 20 to 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649139,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325703,<=,1,1,<=,,MIC,ug.mL-1,,0.5,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,,MIC,ug ml-1,UO_0000274,,0.5
113035,,,5151831,[],CHEMBL1662377,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mosaic variant of mef gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,8.0
113036,,,5151832,[],CHEMBL1662378,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(A) gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,8.0
113037,,,5151833,[],CHEMBL1662379,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(E) gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC50,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC50,ug ml-1,UO_0000274,,4.0
113038,,,5151834,[],CHEMBL1662377,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mosaic variant of mef gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,8.0
113039,,,5151835,[],CHEMBL1662378,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(A) gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,16.0
113040,,,5151836,[],CHEMBL1662379,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(E) gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC90,ug ml-1,UO_0000274,,8.0
113041,,,5151837,[],CHEMBL1662377,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mosaic variant of mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113042,,,5151838,[],CHEMBL1662378,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(A) gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
113043,,,5151839,[],CHEMBL1662379,Antimicrobial activity against Streptococcus pyogenes clinical isolate expressing mef(E) gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649186,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326054,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,2.0
113044,,Not Active,5153263,[],CHEMBL1661213,Inhibition of PAR2-mediated TNFalpha and SLIGKV-NH2-induced interleukin-8 production in normal human epidermal keratinocytes at 10 uM by ELISA,B,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649195,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1326117,,1,0,,,Activity,,,,CHEMBL5963,Homo sapiens,Proteinase-activated receptor 2,9606.0,,,Activity,,,,
113045,,,5153313,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326462,>=,1,1,>=,,MIC,ug.mL-1,,0.031,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC,ug ml-1,UO_0000274,,0.031
113046,,,5153327,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326462,=,1,1,=,,MIC50,ug.mL-1,,0.125,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC50,ug ml-1,UO_0000274,,0.125
113047,,,5153341,[],CHEMBL1665816,Antimicrobial activity against Streptococcus agalactiae clinical isolates by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649463,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326462,>=,1,1,>=,,MIC90,ug.mL-1,,64.0,CHEMBL614622,Streptococcus agalactiae,Streptococcus agalactiae,1311.0,,,MIC90,ug ml-1,UO_0000274,,64.0
113048,,,5155873,[],CHEMBL1656462,Antimicrobial activity against Ureaplasma urealyticum isolate HPA3 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113049,,,5155874,[],CHEMBL1656463,Antimicrobial activity against Ureaplasma urealyticum isolate HPA6 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113050,,,5155875,[],CHEMBL1656464,Antimicrobial activity against Ureaplasma urealyticum isolate HPA12 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113051,,,5155876,[],CHEMBL1656465,Antimicrobial activity against Ureaplasma urealyticum isolate HPA17 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113052,,,5155877,[],CHEMBL1656466,Antimicrobial activity against Ureaplasma parvum SV1 isolate HPA18 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113053,,,5155878,[],CHEMBL1656617,Antimicrobial activity against Ureaplasma urealyticum isolate HPA20 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113054,,,5155879,[],CHEMBL1656618,Antimicrobial activity against Ureaplasma parvum SV6 isolate HPA23 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113055,,,5155880,[],CHEMBL1656619,Antimicrobial activity against Ureaplasma parvum SV14 isolate HPA32 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113056,,,5155881,[],CHEMBL1656620,Antimicrobial activity against Ureaplasma parvum isolate UHWJM after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113057,,,5155882,[],CHEMBL1656621,Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWO10 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,4.0
113058,,,5155883,[],CHEMBL1656622,Antimicrobial activity against Ureaplasma parvum isolate UHWP2 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113059,,,5155884,[],CHEMBL1656623,Antimicrobial activity against Ureaplasma parvum SV1 isolate UHWQ3 after 48 hrs by modified broth microdilution technique,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649200,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326139,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,mg/L,UO_0000274,,0.125
113060,,,5156914,[],CHEMBL1662508,Antimicrobial activity against Helicobacter pylori clinical isolate by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649155,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325757,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,0.02
113061,,,5156915,[],CHEMBL1662507,Antimicrobial activity against Helicobacter pylori ATCC 43504 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649155,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325757,=,1,1,=,,MIC,ug.mL-1,,0.02,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,0.02
113062,,,5157363,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326303,>=,1,1,>=,,MIC,ug.mL-1,,0.007,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.007
113063,,,5157373,[],CHEMBL1660791,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae ATCC 15531 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326303,<=,1,1,<=,,MIC,ug.mL-1,,0.007,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC,ug ml-1,UO_0000274,,0.007
113064,,,5157383,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326303,=,1,1,=,,MIC50,ug.mL-1,,128.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC50,ug ml-1,UO_0000274,,128.0
113065,,,5157393,[],CHEMBL1660790,Antimicrobial activity against macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained from bronchial aspirations expressing 23S rRNA A2063G mutant gene and P1 RFLP type I gene by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649430,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326303,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,,MIC90,ug ml-1,UO_0000274,,128.0
113066,,,5158088,[],CHEMBL1656252,Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325346,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,128.0
113067,,,5158091,[],CHEMBL1656255,Antibacterial activity against Escherichia coli ATCC 25922 by CLSI method in presence of 2 mg/L tachyplesin 3,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325346,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,32.0
113068,,Active,5158092,[],CHEMBL1656256,Antibacterial activity against Escherichia coli by CLSI method in presence of 2 mg/L tachyplesin 3,F,,,BAO_0000201,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1325346,,1,0,,,Inhibition,%,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,INH,,UO_0000187,,
113069,,,5158096,[],CHEMBL1656393,"Antibacterial activity against 1x10'9 CFU Escherichia coli ATCC 25922 infected Wistar rat assessed as rat mortality at 60 mg/kg, iv administered immediately after bacterial challenge measured 72 hrs postinfection (Rvb mortality = 100%)",F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1325346,=,1,0,=,,Activity,%,,66.6,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Activity,%,UO_0000187,,66.6
113070,,,5158098,[],CHEMBL1656395,"Antibacterial activity against 1x10'9 CFU Escherichia coli ATCC 25922 infected Wistar rat assessed as rat bacterial count in peritoneal fluid at 50 mg/kg, iv administered immediately after bacterial challenge measured 72 hrs postinfection (Rvb= 8.86 logCFU/ml)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1325346,=,1,0,=,,log10CFU/ml,,,6.68,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,log10CFU/ml,,,,6.68
113071,,,5158101,[],CHEMBL1656399,Antibacterial activity against Escherichia coli clinical isolates by CLSI method in presence of 2 mg/L tachyplesin 3,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1325346,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,mg/L,UO_0000274,,32.0
113072,,Non-toxic,5158102,[],CHEMBL1656397,"Toxicity in Wistar rat assessed as effect on physiological parameters at 1 mg/kg, iv",T,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649113,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1325346,,1,0,,,Activity,,,,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,,Activity,,,,
113073,,,5161032,[],CHEMBL1655711,"Half life in healthy human at 400 mg, po administered as single dose",A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649161,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Hour,1325779,=,1,1,=,,T1/2,hr,,3.89,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,t1/2,hr,UO_0000032,,3.89
113074,,,5161036,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'infinity', 'standard_type': 'TIME', 'standard_units': None, 'standard_value': None, 'text_value': 'infinity', 'type': 'TIME', 'units': None, 'value': None}]",CHEMBL1655709,"AUC (0 to infinity) in healthy human at 400 mg, po administered as single dose",A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649161,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1325779,=,1,1,=,,AUC,ng.hr.mL-1,,7520.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,AUC,ug.hr/ml,,,7.52
113075,,standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW,5161040,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '400.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '400.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL', 'type': 'ROUTE', 'units': None, 'value': None}]",CHEMBL1655707,"Cmax in healthy human at 400 mg, po administered as single dose",A,,,BAO_0002119,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649161,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1325779,=,1,1,=,,Cmax,nM,,1042.84,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Cmax,ug ml-1,UO_0000065,,0.78
113076,,,5164466,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323843,=,1,1,=,,MIC50,ug.mL-1,,0.03,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC50,ug ml-1,UO_0000274,,0.03
113077,,,5164477,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323843,=,1,1,=,,MIC90,ug.mL-1,,0.12,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC90,ug ml-1,UO_0000274,,0.12
113078,,,5164488,[],CHEMBL1658621,Antimicrobial activity against Neisseria meningitidis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649331,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323843,<=,1,1,<=,,MIC,ug.mL-1,,0.015,CHEMBL614431,Neisseria meningitidis,Neisseria meningitidis,487.0,,,MIC,ug ml-1,UO_0000274,,0.015
113079,,,5164510,[],CHEMBL1658631,Antimicrobial activity against Chlamydia trachomatis isolates,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323857,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.015
113080,,,5164515,[],CHEMBL1658631,Antimicrobial activity against Chlamydia trachomatis isolates,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323857,=,1,1,=,,MIC90,ug.mL-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC90,ug ml-1,UO_0000274,,0.06
113081,,,5164520,[],CHEMBL1658631,Antimicrobial activity against Chlamydia trachomatis isolates,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323857,=,1,0,=,,MBC,ug ml-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.015
113082,,,5164525,[],CHEMBL1658631,Antimicrobial activity against Chlamydia trachomatis isolates,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649332,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323857,=,1,0,=,,MBC90,ug ml-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC90,ug ml-1,UO_0000274,,0.06
113083,,,5176124,[],CHEMBL1666916,Antimicrobial activity against SCCmec type IV vancomycin-intermediate Staphylococcus aureus isolate 06b41 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
113084,,,5176201,[],CHEMBL1666911,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b4k6307 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
113085,,,5176206,[],CHEMBL1666917,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 13b16 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
113086,,,5176207,[],CHEMBL1666920,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 15b52 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
113087,,,5176210,[],CHEMBL1665470,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy39 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113088,,,5176211,[],CHEMBL1665469,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 4sy32 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113089,,,5176212,[],CHEMBL1665530,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 5zjsau3 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113090,,,5176213,[],CHEMBL1665531,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate sh06024 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113091,,,5176215,[],CHEMBL1665532,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06040 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113092,,,5176220,[],CHEMBL1666913,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3578 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113093,,,5176223,[],CHEMBL1666921,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate zj07028 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113094,,,5176225,[],CHEMBL1666923,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate xa07029 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113095,,,5176235,[],CHEMBL1665533,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz06051 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113096,,,5176237,[],CHEMBL1666906,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate bd4768 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113097,,,5176238,[],CHEMBL1666907,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate b2k4781 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113098,,,5176239,[],CHEMBL1666908,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k2345 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113099,,,5176240,[],CHEMBL1666909,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b2k3421 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113100,,,5176241,[],CHEMBL1666910,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b3k5923 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113101,,,5176242,[],CHEMBL1666912,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b5k3529 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113102,,,5176243,[],CHEMBL1666914,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k1642 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113103,,,5176244,[],CHEMBL1666915,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate b6k7974 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113104,,,5176247,[],CHEMBL1666919,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 07b63 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113105,,,5176248,[],CHEMBL1666924,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gz07030 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113106,,,5176250,[],CHEMBL1666925,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate gs07022 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113107,,,5177372,[],CHEMBL1666905,Antimicrobial activity against SCCmec type II vancomycin-intermediate Staphylococcus aureus isolate 6zjsau7 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113108,,,5177385,[],CHEMBL1666918,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate 11b091 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113109,,,5177390,[],CHEMBL1666922,Antimicrobial activity against SCCmec type III vancomycin-intermediate Staphylococcus aureus isolate sh07043 by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649574,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321870,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,64.0
113110,,Not Active,5177404,[],CHEMBL1667427,Antimicrobial activity against Helicobacter pylori clinical isolate expressing 23S rRNA A2143G mutant by Etest,F,,,BAO_0000375,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649575,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1321874,,1,0,,,Activity,,,,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,Activity,,,,
113111,,,5177405,[],CHEMBL1667426,Antimicrobial activity against Helicobacter pylori clinical isolate expressing 23S rRNA A2142G mutant by Etest,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649575,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321874,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,256.0
113112,,,5179181,[],CHEMBL1660029,"Antitubercular activity against Mycobacterium avium infected in C57BL/6J mouse assessed as reduction of CFU counts in spleen at 200 mg/kg, po administered one month post-infection five times weekly for 1 month (Rvb = 7.4 +/- 1.7 log10CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649264,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1322834,=,1,0,=,,log10cfu,,,6.6,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,6.6
113113,,,5179182,[],CHEMBL1660027,"Antitubercular activity against Mycobacterium avium infected in C57BL/6J mouse assessed as reduction of CFU counts in spleen at 200 mg/kg, po administered one month post-infection five times weekly for 4 months (Rvb = 8.9 +/- 0.3 log10CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649264,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1322834,=,1,0,=,,log10cfu,,,7.2,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,7.2
113114,,,5179183,[],CHEMBL1660020,"Antitubercular activity against Mycobacterium avium infected in C57BL/6J mouse assessed as reduction of CFU counts in spleen at 25 mg/kg, po administered one month post-infection five times weekly for 3 months (Rvb = 7.9 +/- 0.7 log10CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649264,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1322834,=,1,0,=,,log10cfu,,,6.2,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,6.2
113115,,,5179184,[],CHEMBL1660030,"Antitubercular activity against Mycobacterium avium infected in C57BL/6J mouse assessed as reduction of CFU counts in spleen at 200 mg/kg, po administered one day post-infection five times weekly for 1 month (Rvb = 8.0 +/- 0.9 log10CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649264,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1322834,=,1,0,=,,log10cfu,,,6.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,6.0
113116,,,5179191,[],CHEMBL1660021,"Antitubercular activity against Mycobacterium avium infected in C57BL/6J mouse assessed as reduction of CFU counts in spleen at 150 mg/kg, sc administered one month post-infection five times weekly for 2 months (Rvb = 9.4 +/- 0.2 log10CFU)",F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649264,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1322834,=,1,0,=,,log10cfu,,,5.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,log10cfu,,,,5.0
113117,,,5179202,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113118,,,5179213,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC50,ug.mL-1,,4e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,0.004
113119,,,5179224,[],CHEMBL1660032,Antibacterial activity against Mycoplasma genitalium by broth dilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC90,ug.mL-1,,8e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,0.008
113120,,,5179235,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,1.6e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.016
113121,,,5179246,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0003035,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC50,ug.mL-1,,3.2e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC50,ug/L,UO_0000274,,0.032
113122,,,5179257,[],CHEMBL1660033,Antibacterial activity against Mycoplasma genitalium by quantitative TaqMan PCR method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC90,ug.mL-1,,6.3e-05,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC90,ug/L,UO_0000274,,0.063
113123,,,5179268,[],CHEMBL1660034,Antibacterial activity against Mycoplasma genitalium G37 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113124,,,5179279,[],CHEMBL1660035,Antibacterial activity against Mycoplasma genitalium M30 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113125,,,5179290,[],CHEMBL1660036,Antibacterial activity against Mycoplasma genitalium R32 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113126,,,5179301,[],CHEMBL1660037,Antibacterial activity against Mycoplasma genitalium TW10-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113127,,,5179312,[],CHEMBL1660038,Antibacterial activity against Mycoplasma genitalium TW10-6G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113128,,,5179323,[],CHEMBL1660039,Antibacterial activity against Mycoplasma genitalium TW48-5G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113129,,,5179334,[],CHEMBL1660040,Antibacterial activity against Mycoplasma genitalium UTMB-10G by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,2e-06,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.002
113130,,,5179345,[],CHEMBL1660041,Antibacterial activity against Mycoplasma genitalium M2282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113131,,,5179356,[],CHEMBL1660042,Antibacterial activity against Mycoplasma genitalium M2300 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113132,,,5179367,[],CHEMBL1660043,Antibacterial activity against Mycoplasma genitalium M2321 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113133,,,5179378,[],CHEMBL1660044,Antibacterial activity against Mycoplasma genitalium M2341 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113134,,,5179389,[],CHEMBL1660045,Antibacterial activity against Mycoplasma genitalium M6257 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113135,,,5179400,[],CHEMBL1660046,Antibacterial activity against Mycoplasma genitalium M6280 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113136,,,5179411,[],CHEMBL1660047,Antibacterial activity against Mycoplasma genitalium M6285 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113137,,,5179422,[],CHEMBL1660048,Antibacterial activity against Mycoplasma genitalium M6286 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113138,,,5180328,[],CHEMBL1659698,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321949,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,25.0
113139,,,5180350,[],CHEMBL1659699,Antimicrobial activity against Mycobacterium chelonae ATCC 35752 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321949,=,1,1,=,,MIC,ug.mL-1,,50.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,50.0
113140,,,5180370,[],CHEMBL1659700,Antimicrobial activity against Mycobacterium chelonae 9917 by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321949,>,1,1,>,,MIC,ug.mL-1,,250.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,250.0
113141,,,5180392,[],CHEMBL1659701,Antimicrobial activity against Mycobacterium chelonae 9917 harboring pZS01 carrying mspA gene by resazurine microtiter assay,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649207,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1321949,=,1,1,=,,MIC,ug.mL-1,,25.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,,MIC,ug ml-1,UO_0000274,,25.0
113142,,,5180476,[],CHEMBL1660173,Antibacterial activity against Mycoplasma genitalium M6328 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113143,,,5180487,[],CHEMBL1660174,Antibacterial activity against Mycoplasma genitalium M6090 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113144,,,5180498,[],CHEMBL1660175,Antibacterial activity against Mycoplasma genitalium M6151 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113145,,,5180509,[],CHEMBL1660176,Antibacterial activity against Mycoplasma genitalium M6282 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113146,,,5180520,[],CHEMBL1660177,Antibacterial activity against Mycoplasma genitalium M6283 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113147,,,5180531,[],CHEMBL1660178,Antibacterial activity against Mycoplasma genitalium M6284 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113148,,,5180542,[],CHEMBL1660179,Antibacterial activity against Mycoplasma genitalium M6287 by broth dilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,Outside typical range,"Values for this activity type are unusually large/small, so may not be accurate",CHEMBL1649265,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1322846,=,1,1,=,,MIC,ug.mL-1,,5e-07,CHEMBL3879801,,NON-PROTEIN TARGET,,,,MIC,ug/L,UO_0000274,,0.0005
113149,,,5183708,[],CHEMBL1664277,Antimicrobial activity against gBLNAS Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
113150,,,5183717,[],CHEMBL1664278,Antimicrobial activity against gLow-BLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
113151,,,5183726,[],CHEMBL1664279,Antimicrobial activity against gBLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
113152,,,5183735,[],CHEMBL1664280,Antimicrobial activity against gBLPAR-TEM1 Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
113153,,,5183744,[],CHEMBL1664281,Antimicrobial activity against gBLPACR-1 Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
113154,,,5183753,[],CHEMBL1664282,Antimicrobial activity against gBLPACR-2 Haemophilus influenzae by agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
113155,,,5183762,[],CHEMBL1664277,Antimicrobial activity against gBLNAS Haemophilus influenzae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,8.0
113156,,,5183771,[],CHEMBL1664278,Antimicrobial activity against gLow-BLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,8.0
113157,,,5183780,[],CHEMBL1664279,Antimicrobial activity against gBLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC50,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC50,ug ml-1,UO_0000274,,8.0
113158,,,5183789,[],CHEMBL1664277,Antimicrobial activity against gBLNAS Haemophilus influenzae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,16.0
113159,,,5183798,[],CHEMBL1664278,Antimicrobial activity against gLow-BLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,16.0
113160,,,5183807,[],CHEMBL1664279,Antimicrobial activity against gBLNAR Haemophilus influenzae by agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649324,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1323805,=,1,1,=,,MIC90,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC90,ug ml-1,UO_0000274,,16.0
113161,,,5188089,[],CHEMBL1663267,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 07D201 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,32.0
113162,,,5188141,[],CHEMBL1663272,Antibacterial activity against erythromycin-susceptible Haemophilus influenzae 07O394 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,mg/L,UO_0000274,,8.0
113163,,,5188142,[],CHEMBL1663271,Antibacterial activity against erythromycin-susceptible Haemophilus influenzae 07O339 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,mg/L,UO_0000274,,8.0
113164,,,5188165,[],CHEMBL1663270,Antibacterial activity against erythromycin-susceptible Haemophilus influenzae 07O114 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,mg/L,UO_0000274,,4.0
113165,,,5188287,[],CHEMBL1663269,Antibacterial activity against erythromycin-susceptible Haemophilus influenzae ATCC 49247 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,mg/L,UO_0000274,,4.0
113166,,,5188297,[],CHEMBL1663268,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 07P390 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,2.0
113167,,,5188339,[],CHEMBL1663255,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae 07H252 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.062
113168,,,5188345,[],CHEMBL1663266,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.031
113169,,,5188364,[],CHEMBL1663264,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 03-233 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,32.0
113170,,,5188365,[],CHEMBL1663259,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis 07T202 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,32.0
113171,,,5188366,[],CHEMBL1663257,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ANS46 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,32.0
113172,,,5188420,[],CHEMBL1663261,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 07A066 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,8.0
113173,,,5188430,[],CHEMBL1663265,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 01-533 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,2.0
113174,,,5188477,[],CHEMBL1663258,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis 07C134 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,0.25
113175,,,5188478,[],CHEMBL1663256,Antibacterial activity against methicillin-susceptible Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
113176,,,5188503,[],CHEMBL1663260,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 07R066 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,0.125
113177,,,5188543,[],CHEMBL1663263,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes 07U086 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,0.031
113178,,,5188544,[],CHEMBL1663262,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes 07U084 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1649395,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1326272,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,0.031
113179,,,5203691,[],CHEMBL1671349,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113180,,,5203692,[],CHEMBL1671350,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing the erm gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
113181,,,5203693,[],CHEMBL1671351,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing the mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113182,,,5203694,[],CHEMBL1671352,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing the erm and mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113183,,,5203695,[],CHEMBL1671353,Antimicrobial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
113184,,,5203696,[],CHEMBL1671354,Antimicrobial activity against penicillin-susceptible Staphylococcus aureus P1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
113185,,,5203697,[],CHEMBL1671355,Antimicrobial activity against erythromycin-susceptible Streptococcus pyogenes S2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
113186,,,5203698,[],CHEMBL1671356,Antimicrobial activity against erythromycin-resistant Streptococcus pyogenes R2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1667745,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1327786,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113187,,,5209516,[],CHEMBL1680555,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,8.0
113188,,,5209521,[],CHEMBL1680554,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of 0.125 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
113189,,,5209526,[],CHEMBL1680553,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of 0.25 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.0
113190,,,5209531,[],CHEMBL1680552,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of 0.5 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
113191,,,5209536,[],CHEMBL1680551,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of 1 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.094
113192,,,5209541,[],CHEMBL1680550,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of NAB739,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,FICI,,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,FICI,,,,0.25
113193,,,5209546,[],CHEMBL1680548,Antibacterial activity against Acinetobacter baumannii F264 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,6.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,6.0
113194,,,5209551,[],CHEMBL1680549,Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of 0.125 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,2.0
113195,,,5209556,[],CHEMBL1680547,Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of 0.25 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,1.5
113196,,,5209561,[],CHEMBL1679840,Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of 0.5 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
113197,,,5209566,[],CHEMBL1679839,Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of 1 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.125
113198,,,5209571,[],CHEMBL1679838,Antibacterial activity against Acinetobacter baumannii F264 by Etest method in presence of NAB739,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,FICI,,,0.333,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,FICI,,,,0.333
113199,,,5209576,[],CHEMBL1679837,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,48.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,48.0
113200,,,5209581,[],CHEMBL1679836,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of 0.125 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
113201,,,5209586,[],CHEMBL1679835,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of 0.25 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
113202,,,5209591,[],CHEMBL1680718,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of 0.5 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,16.0
113203,,,5209596,[],CHEMBL1680719,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of 1 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,12.0
113204,,,5209601,[],CHEMBL1680720,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of 2 ug/ml NAB739,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,3.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,3.0
113205,,,5209606,[],CHEMBL1680721,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853by Etest method in presence of NAB739,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,<=,1,0,<=,,FICI,,,0.46,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,FICI,,,,0.46
113206,,,5209607,[],CHEMBL1680722,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
113207,,,5209612,[],CHEMBL1680723,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.19
113208,,,5209617,[],CHEMBL1680724,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.094,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.094
113209,,,5209622,[],CHEMBL1680725,Ratio of the MIC for Escherichia coli ATCC 25992 in the absence of NAB7061 to MIC for Escherichia coli ATCC 25992 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,170.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,170.0
113210,,,5209627,[],CHEMBL1680726,Antibacterial activity against Escherichia coli IH3080 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,12.0
113211,,,5209632,[],CHEMBL1680727,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.5
113212,,,5209637,[],CHEMBL1680728,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.25
113213,,,5209642,[],CHEMBL1680729,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.047
113214,,,5209647,[],CHEMBL1680730,Ratio of the MIC for Escherichia coli IH3080 in the absence of NAB7061 to MIC for Escherichia coli IH3080 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,190.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,190.0
113215,,,5209652,[],CHEMBL1680731,Antibacterial activity against Escherichia coli IH3080 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.105,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.105
113216,,,5209657,[],CHEMBL1680732,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,12.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,12.0
113217,,,5209662,[],CHEMBL1680733,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,2.0
113218,,,5209667,[],CHEMBL1680734,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 2 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,1.0
113219,,,5209672,[],CHEMBL1680735,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of 4 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.19
113220,,,5209677,[],CHEMBL1680736,Ratio of the MIC for Klebsiella pneumoniae ATCC 13883 in the absence of NAB7061 to MIC for Klebsiella pneumoniae ATCC 13883 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,63.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Ratio,,,,63.0
113221,,,5209682,[],CHEMBL1680737,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,<=,1,1,<=,,MIC,ug.mL-1,,0.141,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.141
113222,,,5209687,[],CHEMBL1680738,Antibacterial activity against Enterobacter cloacae ATCC 23355 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,64.0
113223,,,5209692,[],CHEMBL1680739,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 1 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,32.0
113224,,,5209697,[],CHEMBL1680740,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 2 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,1.5
113225,,,5209702,[],CHEMBL1680741,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.25
113226,,,5209707,[],CHEMBL1680742,Ratio of the MIC for Enterobacter cloacae ATCC 23355 in the absence of NAB7061 to MIC for Enterobacter cloacae ATCC 23355 ATCC 13883 in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,85.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Ratio,,,,85.0
113227,,,5209712,[],CHEMBL1680743,Antibacterial activity against Enterobacter cloacae ATCC 23355 ATCC 13883 by Etest method in presence of NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.273,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.273
113228,,,5209717,[],CHEMBL1680866,Antibacterial activity against Escherichia coli by Etest method in presence of 4 ug/ml NAB7061,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,0.032
113229,,,5209719,[],CHEMBL1680867,Antibacterial activity against Escherichia coli NCTC13353 by Etest method in presence of 4 ug/ml NAB7062,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,1.0
113230,,,5209721,[],CHEMBL1680868,Antibacterial activity against Klebsiella pneumoniae CCUG45421 by Etest method in presence of 4 ug/ml NAB7063,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,24.0
113231,,,5209723,[],CHEMBL1681487,Antibacterial activity against Klebsiella pneumoniae by Etest method in presence of 4 ug/ml NAB7064,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,0.25
113232,,,5209725,[],CHEMBL1681488,Antibacterial activity against Klebsiella oxytoca ATCC 13182 by Etest method in presence of 4 ug/ml NAB7065,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.25
113233,,,5209727,[],CHEMBL1681489,Antibacterial activity against Klebsiella oxytoca CCUG51683 by Etest method in presence of 4 ug/ml NAB7066,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.19,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,MIC,ug ml-1,UO_0000274,,0.19
113234,,,5209729,[],CHEMBL1681490,Antibacterial activity against Enterobacter cloacae CCUG52947 by Etest method in presence of 4 ug/ml NAB7067,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.38,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.38
113235,,,5209731,[],CHEMBL1681491,Antibacterial activity against Enterobacter cloacae by Etest method in presence of 4 ug/ml NAB7068,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.047,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,MIC,ug ml-1,UO_0000274,,0.047
113236,,,5209733,[],CHEMBL1681492,Antibacterial activity against Citrobacter freundii ATCC 8090 by Etest method in presence of 4 ug/ml NAB7069,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,MIC,ug ml-1,UO_0000274,,0.125
113237,,,5209735,[],CHEMBL1681493,Antibacterial activity against Acinetobacter baumannii ATCC 19606 by Etest method in presence of 4 ug/ml NAB7070,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.5
113238,,,5209737,[],CHEMBL1681494,Antibacterial activity against Acinetobacter baumannii by Etest method in presence of 4 ug/ml NAB7071,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,MIC,ug ml-1,UO_0000274,,0.25
113239,,,5209739,[],CHEMBL1681495,Antibacterial activity against Serratia marcescens ATCC 8100 by Etest method in presence of 4 ug/ml NAB7072,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,96.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,MIC,ug ml-1,UO_0000274,,96.0
113240,,,5209741,[],CHEMBL1681496,Antibacterial activity against Proteus mirabilis ATCC 29906 by Etest method in presence of 4 ug/ml NAB7073,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,MIC,ug ml-1,UO_0000274,,24.0
113241,,,5209743,[],CHEMBL1681497,Antibacterial activity against Proteus vulgaris ATCC 13315 by Etest method in presence of 4 ug/ml NAB7074,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,24.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,MIC,ug ml-1,UO_0000274,,24.0
113242,,,5209745,[],CHEMBL1681498,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by Etest method in presence of 4 ug/ml NAB7075,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,32.0
113243,,,5209747,[],CHEMBL1681499,Ratio of the MIC for Escherichia coli in the absence of NAB7061 to MIC for Escherichia coli in the presence of 4 ug/ml of NAB7061,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,90.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,90.0
113244,,,5209749,[],CHEMBL1681500,Ratio of the MIC for Escherichia coli NCTC13353 in the absence of NAB7062 to MIC for Escherichia coli NCTC13353 in the presence of 4 ug/ml of NAB7062,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,>,1,0,>,,Ratio,,,260.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,260.0
113245,,,5209751,[],CHEMBL1681501,Ratio of the MIC for Klebsiella pneumoniae CCUG45421 in the absence of NAB7063 to MIC for Klebsiella pneumoniae CCUG45421 in the presence of 4 ug/ml of NAB7063,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,10.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Ratio,,,,10.0
113246,,,5209753,[],CHEMBL1681502,Ratio of the MIC for Klebsiella pneumoniae in the absence of NAB7064 to MIC for Klebsiella pneumoniae in the presence of 4 ug/ml of NAB7064,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,24.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,Ratio,,,,24.0
113247,,,5209755,[],CHEMBL1681503,Ratio of the MIC for Klebsiella oxytoca ATCC 13182 in the absence of NAB7065 to MIC for Klebsiella oxytoca ATCC 13182 in the presence of 4 ug/ml of NAB7065,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,260.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Ratio,,,,260.0
113248,,,5209757,[],CHEMBL1681504,Ratio of the MIC for Klebsiella oxytoca CCUG51683 in the absence of NAB7066 to MIC for Klebsiella oxytoca CCUG51683 in the presence of 4 ug/ml of NAB7066,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,250.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,,Ratio,,,,250.0
113249,,,5209759,[],CHEMBL1681505,Ratio of the MIC for Enterobacter cloacae CCUG52947 in the absence of NAB7067 to MIC for Enterobacter cloacae CCUG52947 in the presence of 4 ug/ml of NAB7067,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,350.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Ratio,,,,350.0
113250,,,5209761,[],CHEMBL1681506,Ratio of the MIC for Enterobacter cloacae in the absence of NAB7068 to MIC for Enterobacter cloacae in the presence of 4 ug/ml of NAB7068,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,500.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,,Ratio,,,,500.0
113251,,,5209763,[],CHEMBL1681507,Ratio of the MIC for Citrobacter freundii ATCC 8090 in the absence of NAB7069 to MIC for Citrobacter freundii ATCC 8090 in the presence of 4 ug/ml of NAB7069,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,250.0,CHEMBL612615,Citrobacter freundii,Citrobacter freundii,546.0,,,Ratio,,,,250.0
113252,,,5209765,[],CHEMBL1681508,Ratio of the MIC for Acinetobacter baumannii ATCC 19606 in the absence of NAB7070 to MIC for Acinetobacter baumannii ATCC 19606 in the presence of 4 ug/ml of NAB7070,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,50.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Ratio,,,,50.0
113253,,,5209767,[],CHEMBL1678954,Ratio of the MIC for Acinetobacter baumannii in the absence of NAB7071 to MIC for Acinetobacter baumannii in the presence of 4 ug/ml of NAB7071,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,Ratio,,,40.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,,Ratio,,,,40.0
113254,,,5209769,[],CHEMBL1678955,Ratio of the MIC for Serratia marcescens ATCC 8100 in the absence of NAB7072 to MIC for Serratia marcescens ATCC 8100 in the presence of 4 ug/ml of NAB7072,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,<,1,0,<,,Ratio,,,2.0,CHEMBL614593,Serratia marcescens,Serratia marcescens,615.0,,,Ratio,,,,2.0
113255,,,5209771,[],CHEMBL1678956,Ratio of the MIC for Proteus mirabilis ATCC 29906 in the absence of NAB7073 to MIC for Proteus mirabilis ATCC 29906 in the presence of 4 ug/ml of NAB7073,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,<,1,0,<,,Ratio,,,2.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,,Ratio,,,,2.0
113256,,,5209773,[],CHEMBL1678957,Ratio of the MIC for Proteus vulgaris ATCC 13315 in the absence of NAB7074 to MIC for Proteus vulgaris ATCC 13315 in the presence of 4 ug/ml of NAB7074,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,<,1,0,<,,Ratio,,,2.0,CHEMBL614450,Proteus vulgaris,Proteus vulgaris,585.0,,,Ratio,,,,2.0
113257,,,5209775,[],CHEMBL1678958,Ratio of the MIC for Pseudomonas aeruginosa ATCC 27853 in the absence of NAB7075 to MIC for Pseudomonas aeruginosa ATCC 27853 in the presence of 4 ug/ml of NAB7075,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,<,1,0,<,,Ratio,,,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,Ratio,,,,2.0
113258,,,5211908,[],CHEMBL1675696,Antimicrobial activity against Staphylococcus epidermidis SW029 expressing icaA gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332149,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,128.0
113259,,,5211909,[],CHEMBL1675697,Antimicrobial activity against Staphylococcus epidermidis SW036,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332149,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,16.0
113260,,,5211961,[],CHEMBL1676484,Enhancement of biofilm formation Staphylococcus epidermidis ATCC 35984 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,-3.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,-3.9
113261,,,5211962,[],CHEMBL1676483,Antimicrobial activity against Staphylococcus epidermidis SW027 expressing icaA gene assessed as enhancement of biofilm formation at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,62.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,62.3
113262,,,5211963,[],CHEMBL1675560,Enhancement of biofilm formation Staphylococcus epidermidis SW029 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,146.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,146.4
113263,,,5211964,[],CHEMBL1675561,Enhancement of biofilm formation Staphylococcus epidermidis SW032 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,71.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,71.8
113264,,,5211965,[],CHEMBL1675562,Enhancement of biofilm formation Staphylococcus epidermidis SW045 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,32.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,32.2
113265,,,5211966,[],CHEMBL1675563,Enhancement of biofilm formation Staphylococcus epidermidis SW058 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,54.9,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,54.9
113266,,,5211967,[],CHEMBL1675564,Enhancement of biofilm formation Staphylococcus epidermidis SW061 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,46.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,46.3
113267,,,5211968,[],CHEMBL1675565,Enhancement of biofilm formation Staphylococcus epidermidis SW067 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,140.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,140.2
113268,,,5211969,[],CHEMBL1675566,Enhancement of biofilm formation Staphylococcus epidermidis SW085 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,275.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,275.8
113269,,,5211970,[],CHEMBL1675567,Enhancement of biofilm formation Staphylococcus epidermidis SW098 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,112.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,112.8
113270,,,5211971,[],CHEMBL1675568,Enhancement of biofilm formation Staphylococcus epidermidis SW104 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,51.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,51.5
113271,,,5211972,[],CHEMBL1675569,Enhancement of biofilm formation Staphylococcus epidermidis SW126 expressing icaA gene at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,50.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,50.3
113272,,,5211973,[],CHEMBL1675686,Enhancement of biofilm formation Staphylococcus epidermidis SW015 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,78.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,78.6
113273,,,5211974,[],CHEMBL1675687,Enhancement of biofilm formation Staphylococcus epidermidis SW021 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,54.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,54.6
113274,,,5211975,[],CHEMBL1675688,Enhancement of biofilm formation Staphylococcus epidermidis SW036 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,292.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,292.0
113275,,,5211976,[],CHEMBL1675689,Enhancement of biofilm formation Staphylococcus epidermidis SW070 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,155.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,155.6
113276,,,5211977,[],CHEMBL1675690,Enhancement of biofilm formation Staphylococcus epidermidis SW071 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,147.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,147.2
113277,,,5211978,[],CHEMBL1675691,Enhancement of biofilm formation Staphylococcus epidermidis SW082 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,62.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,62.8
113278,,,5211979,[],CHEMBL1675692,Enhancement of biofilm formation Staphylococcus epidermidis SW088 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,201.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,201.5
113279,,,5211980,[],CHEMBL1675693,Enhancement of biofilm formation Staphylococcus epidermidis SW099 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,38.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,38.7
113280,,,5211981,[],CHEMBL1675694,Enhancement of biofilm formation Staphylococcus epidermidis SW115 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,164.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,164.0
113281,,,5211982,[],CHEMBL1675695,Enhancement of biofilm formation Staphylococcus epidermidis SW120 at subinhibitory concentration by microtiter plate assay,F,,,BAO_0001103,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671687,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1332149,=,1,0,=,,Activity,%,,50.6,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,Activity,%,UO_0000187,,50.6
113282,,,5212082,[],CHEMBL1678623,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus SH1000 assessed as inhibition of bacterial biofilm formation by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332647,>,1,0,>,,MBIC,ug ml-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,ug ml-1,UO_0000274,,128.0
113283,,Not Determined,5212087,[],CHEMBL1678622,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 assessed as inhibition of bacterial biofilm formation by CLSI broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332647,,1,0,,,MBIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBIC,,,,
113284,,,5212092,[],CHEMBL1678630,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus SH1000 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332647,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
113285,,Not Determined,5212097,[],CHEMBL1678631,Antimicrobial activity against methicillin-resistant Staphylococcus aureus N315 by CLSI broth microdilution method,F,,,BAO_0002146,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332647,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
113286,,,5212110,[],CHEMBL1678627,fCmax in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 250 mg every 12 hrs,A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332647,=,1,0,=,,fCmax,ug ml-1,,1.15,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,fCmax,ug ml-1,UO_0000274,,1.15
113287,,,5212111,[],CHEMBL1678628,Half life in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 250 mg every 12 hrs,A,,,BAO_0002115,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Hour,1332647,=,1,1,=,,T1/2,hr,,3.91,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,t1/2,hr,UO_0000032,,3.91
113288,,,5212112,"[{'comments': 'extracted from assay description on may 2023', 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg', 'standard_value': '250.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg', 'value': '250.0'}, {'comments': 'extracted from assay description on may 2023', 'relation': '<=', 'result_flag': 0, 'standard_relation': '<=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '24.0', 'text_value': None, 'type': 'TIME', 'units': 'hr', 'value': '24.0'}]",CHEMBL1678629,AUC (0 to 24 hrs) in Staphylococcus aureus in in vitro pharmacokinetic/pharmacodynamic model at 250 mg every 12 hrs,A,,,BAO_0002120,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671745,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332647,=,1,1,=,,AUC,ng.hr.mL-1,,6530.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,AUC,ug/ml.hr,,,6.53
113289,,,5212621,[],CHEMBL1675601,Antimicrobial activity against Helicobacter pylori,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,>=,1,1,>=,,MIC,ug.mL-1,,0.125,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.125
113290,,,5212622,[],CHEMBL1675602,Antimicrobial activity against Helicobacter pylori TS1900,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,1.0
113291,,,5212623,[],CHEMBL1675603,Antimicrobial activity against Helicobacter pylori TS1776,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.5
113292,,,5212624,[],CHEMBL1675604,Antimicrobial activity against compound-resistant Helicobacter pylori harboring 23S rRNA mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,2.0
113293,,,5212625,[],CHEMBL1675605,Antimicrobial activity against clarithromycin-susceptible Helicobacter pylori ATCC 700392 transformant harboring 23S rRNA of Helicobacter pylori TS1900,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.008
113294,,,5212626,[],CHEMBL1675606,Antimicrobial activity against Helicobacter pylori S1900,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,1.0
113295,,,5212627,[],CHEMBL1675607,Antimicrobial activity against Helicobacter pylori TF1,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.5
113296,,,5212628,[],CHEMBL1675608,Antimicrobial activity against Helicobacter pylori TF2,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,0.25
113297,,,5212629,[],CHEMBL1675731,Antimicrobial activity against Helicobacter pylori TF3,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,1.0
113298,,,5212630,[],CHEMBL1675732,Antimicrobial activity against Helicobacter pylori TF4,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671622,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331781,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,mg/L,UO_0000274,,1.0
113299,,,5214949,[],CHEMBL1677456,Antimicrobial activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113300,,,5214950,[],CHEMBL1677457,Antimicrobial activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.015
113301,,,5214951,[],CHEMBL1677458,Antimicrobial activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.015
113302,,,5214952,[],CHEMBL1677459,Antimicrobial activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113303,,,5214953,[],CHEMBL1677460,Antimicrobial activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113304,,,5214954,[],CHEMBL1677461,Antimicrobial activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.015
113305,,,5214955,[],CHEMBL1677462,Antimicrobial activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113306,,,5214956,[],CHEMBL1677463,Antimicrobial activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.015
113307,,,5214957,[],CHEMBL1677464,Bactericidal activity against Chlamydia trachomatis serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.03
113308,,,5214958,[],CHEMBL1677465,Bactericidal activity against Chlamydia trachomatis serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.03
113309,,,5214959,[],CHEMBL1677466,Bactericidal activity against Chlamydia trachomatis serovar F infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.03
113310,,,5214960,[],CHEMBL1677467,Bactericidal activity against Chlamydia trachomatis serovar G infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.06
113311,,,5214961,[],CHEMBL1677468,Bactericidal activity against Chlamydia trachomatis serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.06
113312,,,5214962,[],CHEMBL1677469,Bactericidal activity against Chlamydia trachomatis serovar I infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.03
113313,,,5214963,[],CHEMBL1677470,Bactericidal activity against Chlamydia trachomatis serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.06
113314,,,5214964,[],CHEMBL1677471,Bactericidal activity against Chlamydia trachomatis serovar K infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.03
113315,,,5214965,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113316,,,5214966,[],CHEMBL1677473,Antimicrobial activity against Chlamydia trachomatis Bour serovar E infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.03
113317,,,5214967,[],CHEMBL1677474,Antimicrobial activity against Chlamydia trachomatis 580 serovar H infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.06
113318,,,5214968,[],CHEMBL1677475,Antimicrobial activity against Chlamydia trachomatis UW-36 serovar J infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0002146,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MIC,ug ml-1,UO_0000274,,0.06
113319,,,5214995,[],CHEMBL1677472,Antimicrobial activity against Chlamydia trachomatis Ic Cal-8 serovar D infected in pig LLC-MK2 cells monolayers assessed as reduction in number of microbial inclusions after 48 hrs,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671766,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332747,=,1,0,=,,MBC,ug ml-1,,0.06,CHEMBL614606,Chlamydia trachomatis,Chlamydia trachomatis,813.0,,,MBC,ug ml-1,UO_0000274,,0.06
113320,,,5221245,[],CHEMBL1679009,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 49951 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
113321,,,5221253,[],CHEMBL1679010,Antimicrobial activity against methicillin-susceptible Staphylococcus aureus ATCC 13709 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
113322,,,5221261,[],CHEMBL1679011,Antimicrobial activity against methicillin-resistant Staphylococcus aureus NB01021 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113323,,,5221269,[],CHEMBL1679012,Antimicrobial activity against Streptococcus pneumoniae ATCC 6301 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,=,1,1,=,,MIC,ug.mL-1,,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.015
113324,,,5221277,[],CHEMBL1679013,Antimicrobial activity against Streptococcus pneumoniae ATCC 6303 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113325,,,5221285,[],CHEMBL1679014,Antimicrobial activity against multiple drug-resistant Streptococcus pneumoniae ATCC 700677 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332003,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
113326,,,5221299,[],CHEMBL1679022,Antimicrobial activity against methicillin susceptible Staphylococcus aureus ATCC 49951 infected in po dosed NMRI mouse treated 1 and 5 hrs post infection,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332003,=,1,1,=,,ED50,mg.kg-1,,7.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,7.7
113327,,,5221303,[],CHEMBL1679023,Antimicrobial activity against methicillin susceptible Staphylococcus aureus ATCC 49951 infected in sc dosed NMRI mouse treated 1 and 5 hrs post infection,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332003,=,1,1,=,,ED50,mg.kg-1,,1.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,1.2
113328,,,5221306,[],CHEMBL1679024,Antimicrobial activity against methicillin susceptible Staphylococcus aureus ATCC 13709 infected in po dosed NMRI mouse treated 1 and 5 hrs post infection,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332003,=,1,1,=,,ED50,mg.kg-1,,8.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,ED50,mg kg-1,UO_0000308,,8.7
113329,,,5221316,[],CHEMBL1674312,Antimicrobial activity against Streptococcus pneumoniae ATCC 6303 infected in po dosed NMRI mouse administered thrice daily for 4 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332003,=,1,1,=,,ED50,mg.kg-1,,2.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,2.1
113330,,,5221317,[],CHEMBL1674313,Antimicrobial activity against multiple drug resistant Streptococcus pneumoniae ATCC 700677 infected in po dosed BALB/c mouse administered twice daily for 3 days,F,,,BAO_0003036,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671663,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332003,>,1,1,>,,ED50,mg.kg-1,,60.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,ED50,mg kg-1,UO_0000308,,60.0
113331,,,5221962,[],CHEMBL1680962,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671842,ACS Med Chem Lett,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331243,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113332,,,5221963,[],CHEMBL1680963,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 205,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671842,ACS Med Chem Lett,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331243,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113333,,Not Determined,5225755,[],CHEMBL1677380,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 200 uM by spectrofluorometric assay,B,,,BAO_0002114,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1332423,,1,0,,,Time,,,,CHEMBL612545,,Unchecked,,,,Time,,,,
113334,,,5225782,[],CHEMBL1677379,Inhibition of acrAB AcrAB-TolC-mediated Nile Red efflux in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as time needed for 50% efflux after energization with 50 mM glucose at 1000 uM by spectrofluorometric assay,B,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671720,Antimicrob Agents Chemother,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Hour,1332423,=,1,1,=,,TIME,hr,,0.005556,CHEMBL612545,,Unchecked,,,,Time,s,UO_0000032,,20.0
113335,,,5229224,[],CHEMBL1679884,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331913,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
113336,,,5229227,[],CHEMBL1679883,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331913,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
113337,,,5229233,[],CHEMBL1679882,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331913,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
113338,,,5229251,[],CHEMBL1679881,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-N623S-Q624S mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
113339,,,5229264,[],CHEMBL1679880,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
113340,,,5229278,[],CHEMBL1679174,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-I626M mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
113341,,,5229293,[],CHEMBL1679173,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
113342,,,5229305,[],CHEMBL1679172,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-N616 mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
113343,,,5229319,[],CHEMBL1679171,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
113344,,,5229331,[],CHEMBL1679170,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,4.0
113345,,,5229345,[],CHEMBL1679169,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-F628F mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,512.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,512.0
113346,,,5229356,[],CHEMBL1679885,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene to MIC for Escherichia coli K-12 3-AG300,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331913,=,1,0,=,,Ratio,,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,Ratio,,,,4.0
113347,,,5229362,[],CHEMBL1679886,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-S623N mutant gene,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331913,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,128.0
113348,,,5230439,[],CHEMBL1679830,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331716,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,16.0
113349,,,5230445,[],CHEMBL1679827,Antibacterial activity against Escherichia coli ATCC 25992 by Etest method in presence of NAB7061,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1671867,Antimicrob Agents Chemother,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1331716,=,1,0,=,,FICI,,,0.137,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,FICI,,,,0.137
113350,,Active,5309674,[],CHEMBL1695140,Drug uptake in human THP1 cells after 24 hrs in presence of verapamil,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,,1,0,,,Drug uptake,,,,CHEMBL614245,Homo sapiens,THP-1,9606.0,,,Drug uptake,,,,
113351,,Active,5309678,[],CHEMBL1695141,Drug uptake in human THP1 cells after 24 hrs in presence of gemfibrozil,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,,1,0,,,Drug uptake,,,,CHEMBL614245,Homo sapiens,THP-1,9606.0,,,Drug uptake,,,,
113352,,Not Active,5309688,[],CHEMBL1695364,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 at pH 5.5 to 7.4 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,,1,0,,,MIC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,,,,
113353,,Not Active,5309692,[],CHEMBL1695365,Antibacterial activity against Listeria monocytogenes EGD at pH 5.5 to 7.4 after 24 hrs,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,,1,0,,,MIC,,,,CHEMBL614974,Listeria monocytogenes,Listeria monocytogenes,1639.0,,,MIC,,,,
113354,,,5309704,[],CHEMBL1695371,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 assessed as decrease of CFU after 24 hrs relative to initial inoculum,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,=,1,0,=,,log10cfu,,,-1.41,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,-1.41
113355,,,5309708,[],CHEMBL1695372,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 assessed as decrease of CFU after 24 hrs,F,,,BAO_0000188,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337504,=,1,1,=,,EC50,ug.mL-1,,0.8,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,EC50,mg/L,UO_0000274,,0.8
113356,,,5310770,[],CHEMBL1695373,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 assessed as concentration required to no apparent bacterial growth after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,=,1,0,=,,Activity,mg/L,,1.32,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg/L,,,1.32
113357,,,5310774,[],CHEMBL1695499,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 infected in human THP1 cells assessed as decrease of CFU after 24 hrs relative to initial inoculum,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,=,1,0,=,,log10cfu,,,-0.18,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,log10cfu,,,,-0.18
113358,,,5310778,[],CHEMBL1695500,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 infected in human THP1 cells assessed as decrease of CFU after 24 hrs,F,,,BAO_0000188,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337504,=,1,1,=,,EC50,ug.mL-1,,0.046,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,EC50,mg/L,UO_0000274,,0.046
113359,,,5310782,[],CHEMBL1695501,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 25923 infected in human THP1 cells assessed as concentration required to no apparent bacterial growth after 24 hrs,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1687740,Antimicrob Agents Chemother,2009.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1337504,=,1,0,=,,Activity,mg/L,,0.84,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Activity,mg/L,,,0.84
113360,,Negative,5315904,[],CHEMBL1697691,Literature-mined public compounds from Lowe et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697681,Mol Pharm,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1339712,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
113361,,HH: Evidence of human hepatotoxicity,5316445,[],CHEMBL1697722,Literature-mined public compounds from Greene et al multi-species hepatotoxicity modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697692,Chem Res Toxicol,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1340268,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
113362,,DILI positive (test set),5316866,[],CHEMBL1697730,Human drug-induced liver injury (DILI) modelling dataset from Ekins et al,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697723,Drug Metab Dispos,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1340684,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
113363,,drug-induced liver injury reported,5317229,[],CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341015,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
113364,,drug-induced liver injury reported,5318180,[],CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341015,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
113365,,no drug-induced liver injury reported,5319131,[],CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697731,Chem Res Toxicol,2010.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341015,,1,0,,,Hepatotoxicity,,,,CHEMBL1697861,,Hepatotoxicity,,,,Hepatotoxicity,,,,
113366,,Inactive,5320590,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,Composite Activity - Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Score,,,,
113367,,,5320591,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,Composite Activity - Active,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Active,,,,0.0
113368,,,5320592,[],CHEMBL1697797,"FDA HLAED, liver enzyme composite activity",A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,Composite Activity - Marginal,,,3.0,CHEMBL1697861,,Hepatotoxicity,,,,Composite Activity - Marginal,,,,3.0
113369,,Marginally Active,5320593,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,Alkaline Phosphatase Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Activity Score,,,,
113370,,,5320594,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,Alkaline Phosphatase Increase - Index Value,,,3.1,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Index Value,,,,3.1
113371,,,5320595,[],CHEMBL1697798,"FDA HLAED, alkaline phosphatase increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,>=,1,0,>=,,Alkaline Phosphatase Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,Alkaline Phosphatase Increase - Number of Reports,,,,4.0
113372,,Marginally Active,5320596,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,SGOT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Activity Score,,,,
113373,,,5320597,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,SGOT Increase - Index Value,,,3.8,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Index Value,,,,3.8
113374,,,5320598,[],CHEMBL1697799,"FDA HLAED, serum glutamic oxaloacetic transaminase (SGOT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,>=,1,0,>=,,SGOT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGOT Increase - Number of Reports,,,,4.0
113375,,Marginally Active,5320599,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,SGPT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Activity Score,,,,
113376,,,5320600,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,SGPT Increase - Index Value,,,3.3,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Index Value,,,,3.3
113377,,,5320601,[],CHEMBL1697800,"FDA HLAED, serum glutamic pyruvic transaminase (SGPT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,>=,1,0,>=,,SGPT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,SGPT Increase - Number of Reports,,,,4.0
113378,,Inactive,5320602,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,LDH Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Activity Score,,,,
113379,,,5320603,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,LDH Increase - Index Value,,,1.4,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Index Value,,,,1.4
113380,,,5320604,[],CHEMBL1697801,"FDA HLAED, lactate dehydrogenase (LDH) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,>=,1,0,>=,,LDH Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,LDH Increase - Number of Reports,,,,4.0
113381,,Inactive,5320605,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,,1,0,,,GGT Increase - Activity Score,,,,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Activity Score,,,,
113382,,,5320606,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,=,1,0,=,,GGT Increase - Index Value,,,1.5,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Index Value,,,,1.5
113383,,,5320607,[],CHEMBL1697802,"FDA HLAED, gamma-glutamyl transferase (GGT) increase",A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697781,Curr Drug Discov Technol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1341964,>=,1,0,>=,,GGT Increase - Number of Reports,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,GGT Increase - Number of Reports,,,,4.0
113384,,Negative: confirmed by electron microscopy,5328822,[],CHEMBL1697855,Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1697821,Toxicol Mech Methods,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1342400,,1,0,,,Phospholipidosis,,,,CHEMBL1626541,,Phospholipidosis,,,,Phospholipidosis,,,,
113385,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",Substrate,6074473,[],CHEMBL1743273,"Clinically relevant substrates of human liver microsomal P450 enzymes, isoform CYP3A4",A,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743201,,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1394330,,1,0,,,Activity,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Activity,,,,
113386,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Inhibitor,6074639,[],CHEMBL1743282,"Clinically relevant inhibitors of human liver microsomal P450 enzymes, isoform CYP3A4",A,,,BAO_0000375,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743201,,2008.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1394330,,1,0,,,Activity,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Activity,,,,
113387,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10950845,6075111,[],CHEMBL1743430,Mechanism based inhibition of human cytochrome P450 3A4,A,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,5.26,0,http://www.openphacts.org/units/Nanomolar,1394572,=,1,1,=,,Ki,nM,,5490.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,KI,uM,UO_0000065,,5.49
113388,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",Cytochrome P450 mechanistic inhibitor: PMID 10950845,6075114,[],CHEMBL1743430,Mechanism based inhibition of human cytochrome P450 3A4,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1743341,Curr Drug Metab,2005.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1394572,=,1,0,=,,Kinact,min-1,,0.072,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Kinact,min-1,,,0.072
113389,,,6184837,[],CHEMBL1775524,Antiparasitic activity against Toxoplasma gondii 2F-1 expressing yellow fluorescent protein infected in HFF after 4 days,F,,,BAO_0000190,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.51,0,http://www.openphacts.org/units/Nanomolar,1422189,=,1,1,=,,IC50,nM,,31000.0,CHEMBL612888,Toxoplasma gondii,Toxoplasma gondii,5811.0,,,IC50,uM,UO_0000065,,31.0
113390,,,6184864,[],CHEMBL1775525,Antibacterial activity against Bacillus subtilis,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1422189,=,1,1,=,,MIC,nM,,40.0,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,,MIC,uM,UO_0000065,,0.04
113391,,,6184895,[],CHEMBL1775526,Cytotoxicity against HFF after 48 hrs by MTS assay,A,,,BAO_0000187,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1772948,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1422189,=,1,1,=,,CC50,nM,,260000.0,CHEMBL614071,Homo sapiens,HFF,9606.0,,,CC50,uM,UO_0000065,,260.0
113392,,,6265288,[],CHEMBL1798378,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436152,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.12
113393,,,6265309,[],CHEMBL1798379,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436152,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113394,,,6265330,[],CHEMBL1798484,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436152,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113395,,,6265351,[],CHEMBL1798531,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing erm and mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436152,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113396,,,6265372,[],CHEMBL1798532,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1795320,Eur J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1436152,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
113397,,inactive,6721461,[],CHEMBL1794461,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262],F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1211178,,7,1,,,Potency,nM,,517.4,CHEMBL3885569,Homo sapiens,GTP-binding nuclear protein Ran/Importin subunit beta-1/Snurportin-1,9606.0,,,Potency,uM,UO_0000065,,0.5174
113398,,active,6850208,[],CHEMBL1794494,PUBCHEM_BIOASSAY: Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488938],F,,,BAO_0000186,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.64,0,http://www.openphacts.org/units/Nanomolar,1211178,=,7,1,=,,AC50,nM,,23104.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,AC50,uM,UO_0000065,,23.104
113399,,inactive,7039788,[],CHEMBL1794512,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Cell Surface uPA Generation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493178],F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1211178,,7,1,,,Potency,nM,,5623.4,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,5.6234
113400,,,7566398,[],CHEMBL1908285,Apparent permeability (Papp) from apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539067,=,1,0,=,,Papp,nm/s,,10.8,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,10.8
113401,,,7566464,[],CHEMBL1908286,Apparent permeability (Papp) from basolateral to apical side determined in MDR1-MDCKII cells,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539067,=,1,0,=,,Papp,nm/s,,336.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Papp,nm/s,,,336.0
113402,,Effluxed: Y,7566530,[],CHEMBL1908289,Ratio of apparent permeability from basolateral to apical side over apical to basolateral side determined in MDR1-MDCKII cells,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539067,=,1,0,=,,Ratio_Papp,,,31.3,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_Papp,,,,31.3
113403,,ATPase Activator: Y,7566590,[],CHEMBL1908291,Drug-stimulated Pgp ATPase activity ratio determined in MDR1-Sf9 cell membranes with test compound at a concentration of 20uM,B,,,BAO_0000179,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539067,=,1,0,=,,Ratio_ATPase activity,,,3.55,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Ratio_ATPase activity,,,,3.55
113404,,Calcein-AM Inhibitor: N,7566650,[],CHEMBL1908292,Inhibition of Pgp expressed in MDR1-MDCKII cells measured by calcein-AM assay,B,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1539067,=,1,0,=,,% maximum response,%,,2.71,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,% maximum response,%,UO_0000187,,2.71
113405,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708180,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,IC50,,,,
113406,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708181,[],CHEMBL1909212,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL220,Homo sapiens,Acetylcholinesterase,9606.0,,,Ki,,,,
113407,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708182,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,IC50,,,,
113408,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708183,[],CHEMBL1909213,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL226,Homo sapiens,Adenosine A1 receptor,9606.0,,,Ki,,,,
113409,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708184,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,IC50,,,,
113410,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708185,[],CHEMBL1909214,DRUGMATRIX: Adenosine A2A radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL251,Homo sapiens,Adenosine A2a receptor,9606.0,,,Ki,,,,
113411,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708186,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,IC50,,,,
113412,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708187,[],CHEMBL1909215,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL256,Homo sapiens,Adenosine A3 receptor,9606.0,,,Ki,,,,
113413,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708188,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113414,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708189,[],CHEMBL1909084,DRUGMATRIX: Sodium/nucleoside co-transporter radioligand binding (ligand: nitrobenzylthioinosine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113415,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708190,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,IC50,,,,
113416,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708191,[],CHEMBL1909085,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL319,Rattus norvegicus,Alpha-1a adrenergic receptor,10116.0,,,Ki,,,,
113417,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708192,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,IC50,,,,
113418,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708193,[],CHEMBL1909086,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL315,Rattus norvegicus,Alpha-1b adrenergic receptor,10116.0,,,Ki,,,,
113419,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708194,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,IC50,,,,
113420,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7708195,[],CHEMBL1909087,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL223,Homo sapiens,Alpha-1d adrenergic receptor,9606.0,,,Ki,,,,
113421,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710278,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,IC50,,,,
113422,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710279,[],CHEMBL1909088,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1867,Homo sapiens,Alpha-2a adrenergic receptor,9606.0,,,Ki,,,,
113423,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710280,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,IC50,,,,
113424,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710281,[],CHEMBL1909089,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1942,Homo sapiens,Alpha-2b adrenergic receptor,9606.0,,,Ki,,,,
113425,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710282,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,IC50,,,,
113426,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710283,[],CHEMBL1909090,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1916,Homo sapiens,Alpha-2c adrenergic receptor,9606.0,,,Ki,,,,
113427,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710284,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,IC50,,,,
113428,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710285,[],CHEMBL1909091,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL213,Homo sapiens,Beta-1 adrenergic receptor,9606.0,,,Ki,,,,
113429,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710286,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,IC50,,,,
113430,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710287,[],CHEMBL1909092,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL210,Homo sapiens,Beta-2 adrenergic receptor,9606.0,,,Ki,,,,
113431,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710288,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,IC50,,,,
113432,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710289,[],CHEMBL1909093,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL246,Homo sapiens,Beta-3 adrenergic receptor,9606.0,,,Ki,,,,
113433,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710290,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,IC50,,,,
113434,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710291,[],CHEMBL1909094,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL222,Homo sapiens,Norepinephrine transporter,9606.0,,,Ki,,,,
113435,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710292,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,IC50,,,,
113436,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710293,[],CHEMBL1909095,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2622,Rattus norvegicus,Aldose reductase,10116.0,,,Ki,,,,
113437,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710294,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,IC50,,,,
113438,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710295,[],CHEMBL1909096,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4607,Homo sapiens,Angiotensin II type 2 (AT-2) receptor,9606.0,,,Ki,,,,
113439,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710296,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113440,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710297,[],CHEMBL1909097,"DRUGMATRIX: ATPase, Na+/K+ enzyme inhibition (substrate: ATP)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113441,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710298,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113442,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710299,[],CHEMBL1909098,DRUGMATRIX: Atrial Natriuretic Factor (ANF) radioligand binding (ligand: [125I] ANF (rat)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113443,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710300,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000190,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113444,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710301,[],CHEMBL1909099,DRUGMATRIX: beta-Lactamase enzyme inhibition (substrate: Nitrocefin),B,,,BAO_0000192,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113445,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710302,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,IC50,,,,
113446,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710303,[],CHEMBL1909100,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3157,Homo sapiens,Bradykinin B2 receptor,9606.0,,,Ki,,,,
113447,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710304,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,IC50,,,,
113448,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710305,[],CHEMBL1909101,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1832,Homo sapiens,Calcitonin receptor,9606.0,,,Ki,,,,
113449,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710306,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113450,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710307,[],CHEMBL1909102,"DRUGMATRIX: Calcium Channel Type L, Benzothiazepine radioligand binding (ligand: [3H] Diltiazem)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113451,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710308,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113452,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710309,[],CHEMBL1909103,"DRUGMATRIX: Calcium Channel Type L, Dihydropyridine radioligand binding (ligand: [3H] Nitrendipine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113453,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710310,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113454,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710311,[],CHEMBL1909121,"DRUGMATRIX: Calcium Channel Type L, Phenylalkylamine radioligand binding (ligand: [3H] (-)-Desmethoxyverapamil (D-888))",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113455,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710312,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,IC50,,,,
113456,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710313,[],CHEMBL1909122,DRUGMATRIX: Cannabinoid CB1 radioligand binding (ligand: [3H] SR141716A),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL218,Homo sapiens,Cannabinoid CB1 receptor,9606.0,,,Ki,,,,
113457,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710314,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,IC50,,,,
113458,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710315,[],CHEMBL1909123,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL205,Homo sapiens,Carbonic anhydrase II,9606.0,,,Ki,,,,
113459,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710316,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,IC50,,,,
113460,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710317,[],CHEMBL1909124,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4015,Homo sapiens,C-C chemokine receptor type 2,9606.0,,,Ki,,,,
113461,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710318,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,IC50,,,,
113462,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710319,[],CHEMBL1909125,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2414,Homo sapiens,C-C chemokine receptor type 4,9606.0,,,Ki,,,,
113463,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710320,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,IC50,,,,
113464,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710321,[],CHEMBL1909126,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL274,Homo sapiens,C-C chemokine receptor type 5,9606.0,,,Ki,,,,
113465,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710322,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,IC50,,,,
113466,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710323,[],CHEMBL1909127,DRUGMATRIX: Chemokine CXCR1 (IL-8A),B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4029,Homo sapiens,Interleukin-8 receptor A,9606.0,,,Ki,,,,
113467,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710324,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,IC50,,,,
113468,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710325,[],CHEMBL1909128,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2434,Homo sapiens,Interleukin-8 receptor B,9606.0,,,Ki,,,,
113469,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710326,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,IC50,,,,
113470,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710327,[],CHEMBL1909129,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1901,Homo sapiens,Cholecystokinin A receptor,9606.0,,,Ki,,,,
113471,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710328,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,IC50,,,,
113472,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710329,[],CHEMBL1909130,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL221,Homo sapiens,Cyclooxygenase-1,9606.0,,,Ki,,,,
113473,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710330,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,IC50,,,,
113474,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710331,[],CHEMBL1909131,DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL230,Homo sapiens,Cyclooxygenase-2,9606.0,,,Ki,,,,
113475,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710332,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,IC50,,,,
113476,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710333,[],CHEMBL1909132,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,Ki,,,,
113477,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710334,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,IC50,,,,
113478,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710335,[],CHEMBL1909133,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL5282,Homo sapiens,Cytochrome P450 2A6,9606.0,,,Ki,,,,
113479,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710336,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,IC50,,,,
113480,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710337,[],CHEMBL1909134,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,Ki,,,,
113481,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710338,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,IC50,,,,
113482,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710339,[],CHEMBL1909135,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,Ki,,,,
113483,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710340,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,IC50,,,,
113484,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710341,[],CHEMBL1909136,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,Ki,,,,
113485,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710342,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,IC50,,,,
113486,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710343,[],CHEMBL1909137,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL5281,Homo sapiens,Cytochrome P450 2E1,9606.0,,,Ki,,,,
113487,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710344,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,IC50,,,,
113488,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710345,[],CHEMBL1909138,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ki,,,,
113489,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710346,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,IC50,,,,
113490,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710347,[],CHEMBL1909139,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2056,Homo sapiens,Dopamine D1 receptor,9606.0,,,Ki,,,,
113491,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710348,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,IC50,,,,
113492,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710349,[],CHEMBL1909140,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL217,Homo sapiens,Dopamine D2 receptor,9606.0,,,Ki,,,,
113493,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710350,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,IC50,,,,
113494,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710351,[],CHEMBL1909141,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL234,Homo sapiens,Dopamine D3 receptor,9606.0,,,Ki,,,,
113495,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710352,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,IC50,,,,
113496,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710353,[],CHEMBL1909142,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL219,Homo sapiens,Dopamine D4 receptor,9606.0,,,Ki,,,,
113497,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710354,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,IC50,,,,
113498,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710355,[],CHEMBL1909143,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL238,Homo sapiens,Dopamine transporter,9606.0,,,Ki,,,,
113499,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710356,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,IC50,,,,
113500,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710357,[],CHEMBL1909144,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL252,Homo sapiens,Endothelin receptor ET-A,9606.0,,,Ki,,,,
113501,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710358,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,IC50,,,,
113502,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710359,[],CHEMBL1909145,DRUGMATRIX: Estrogen ERalpha radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL206,Homo sapiens,Estrogen receptor alpha,9606.0,,,Ki,,,,
113503,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710360,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,IC50,,,,
113504,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710361,[],CHEMBL1909146,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL242,Homo sapiens,Estrogen receptor beta,9606.0,,,Ki,,,,
113505,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710362,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113506,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710363,[],CHEMBL1909147,"DRUGMATRIX: GABAA, Muscimol, Central radioligand binding (ligand: [3H] Muscimol)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113507,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710364,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113508,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710365,[],CHEMBL1909148,"DRUGMATRIX: GABAA, Flunitrazepam, Central radioligand binding (ligand: [3H] Flunitrazepam)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113509,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710366,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113510,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710367,[],CHEMBL1909149,"DRUGMATRIX: GABAA, Chloride Channel, TBOB radioligand binding (ligand: [3H] TBOB)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113511,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710368,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,IC50,,,,
113512,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710369,[],CHEMBL1909150,DRUGMATRIX: Glucocorticoid radioligand binding (ligand: [3H] Dexamethasone),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2034,Homo sapiens,Glucocorticoid receptor,9606.0,,,Ki,,,,
113513,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710370,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113514,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710371,[],CHEMBL1909151,"DRUGMATRIX: Glutamate, AMPA radioligand binding (ligand: [3H] AMPA)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113515,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710372,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113516,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710373,[],CHEMBL1909152,"DRUGMATRIX: Glutamate, Kainate radioligand binding (ligand: [3H] Kainic acid)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113517,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710374,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113518,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710375,[],CHEMBL1909153,"DRUGMATRIX: Glutamate, NMDA, Agonism radioligand binding (ligand: [3H] CGP-39653)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113519,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710376,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113520,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710377,[],CHEMBL1909154,"DRUGMATRIX: Glutamate, NMDA, Phencyclidine radioligand binding (ligand: [3H] TCP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113521,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710378,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,IC50,,,,
113522,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710379,[],CHEMBL1909155,"DRUGMATRIX: Glycine, Strychnine-Sensitive radioligand binding (ligand: [3H] Strychnine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3392921,Rattus norvegicus,Glycine receptor,10116.0,,,Ki,,,,
113523,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710380,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,IC50,,,,
113524,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710381,[],CHEMBL1909156,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL231,Homo sapiens,Histamine H1 receptor,9606.0,,,Ki,,,,
113525,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710382,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,IC50,,,,
113526,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710383,[],CHEMBL1909157,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1941,Homo sapiens,Histamine H2 receptor,9606.0,,,Ki,,,,
113527,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710384,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,IC50,,,,
113528,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710385,[],CHEMBL1909158,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL402,Homo sapiens,HMG-CoA reductase,9606.0,,,Ki,,,,
113529,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710386,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113530,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710387,[],CHEMBL1909159,"DRUGMATRIX: Imidazoline I2, Central radioligand binding (ligand: [3H] Idazoxan)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113531,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710388,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,IC50,,,,
113532,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710389,[],CHEMBL1909160,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL5486,Rattus norvegicus,Insulin receptor,10116.0,,,Ki,,,,
113533,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710390,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113534,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710391,[],CHEMBL1909161,DRUGMATRIX: Interleukin IL-1 radioligand binding (ligand: [125I] interleukin 1beta),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113535,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710392,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113536,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710393,[],CHEMBL1909162,"DRUGMATRIX: Leukotriene, BLT (LTB4) radioligand binding (ligand: [3H]LTB4)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113537,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710394,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,IC50,,,,
113538,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710395,[],CHEMBL1909163,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1909043,Cavia porcellus,Leukotriene C4 synthase,10141.0,,,Ki,,,,
113539,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710396,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,IC50,,,,
113540,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710397,[],CHEMBL1909164,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1798,Homo sapiens,Cysteinyl leukotriene receptor 1,9606.0,,,Ki,,,,
113541,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710398,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,IC50,,,,
113542,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710399,[],CHEMBL1909165,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4358,Oryctolagus cuniculus,Arachidonate 15-lipoxygenase,9986.0,,,Ki,,,,
113543,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710400,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,IC50,,,,
113544,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710401,[],CHEMBL1909166,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4644,Homo sapiens,Melanocortin receptor 3,9606.0,,,Ki,,,,
113545,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710402,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,IC50,,,,
113546,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710403,[],CHEMBL1909167,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL259,Homo sapiens,Melanocortin receptor 4,9606.0,,,Ki,,,,
113547,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710404,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,IC50,,,,
113548,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710405,[],CHEMBL1909168,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4608,Homo sapiens,Melanocortin receptor 5,9606.0,,,Ki,,,,
113549,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710406,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,IC50,,,,
113550,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710407,[],CHEMBL1909169,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1951,Homo sapiens,Monoamine oxidase A,9606.0,,,Ki,,,,
113551,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7710408,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,IC50,,,,
113552,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712465,[],CHEMBL1909170,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL216,Homo sapiens,Muscarinic acetylcholine receptor M1,9606.0,,,Ki,,,,
113553,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712466,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,IC50,,,,
113554,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712467,[],CHEMBL1909171,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL211,Homo sapiens,Muscarinic acetylcholine receptor M2,9606.0,,,Ki,,,,
113555,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712468,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,IC50,,,,
113556,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712469,[],CHEMBL1909172,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL245,Homo sapiens,Muscarinic acetylcholine receptor M3,9606.0,,,Ki,,,,
113557,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712470,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,IC50,,,,
113558,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712471,[],CHEMBL1909173,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1821,Homo sapiens,Muscarinic acetylcholine receptor M4,9606.0,,,Ki,,,,
113559,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712472,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,IC50,,,,
113560,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712473,[],CHEMBL1909174,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2035,Homo sapiens,Muscarinic acetylcholine receptor M5,9606.0,,,Ki,,,,
113561,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712474,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,IC50,,,,
113562,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712475,[],CHEMBL1909175,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4777,Homo sapiens,Neuropeptide Y receptor type 1,9606.0,,,Ki,,,,
113563,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712476,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,IC50,,,,
113564,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712477,[],CHEMBL1909176,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4018,Homo sapiens,Neuropeptide Y receptor type 2,9606.0,,,Ki,,,,
113565,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712478,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113566,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712479,[],CHEMBL1909177,DRUGMATRIX: Nicotinic Acetylcholine radioligand binding (ligand: [125I] Epibatidine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113567,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712480,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,IC50,,,,
113568,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712481,[],CHEMBL1909178,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3048,Rattus norvegicus,"Nitric-oxide synthase, brain",10116.0,,,Ki,,,,
113569,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712482,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,IC50,,,,
113570,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712483,[],CHEMBL1909179,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3464,Mus musculus,"Nitric oxide synthase, inducible",10090.0,,,Ki,,,,
113571,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712484,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,IC50,,,,
113572,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712485,[],CHEMBL1909180,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL236,Homo sapiens,Delta opioid receptor,9606.0,,,Ki,,,,
113573,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712486,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,IC50,,,,
113574,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712487,[],CHEMBL1909181,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL237,Homo sapiens,Kappa opioid receptor,9606.0,,,Ki,,,,
113575,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712488,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,IC50,,,,
113576,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712489,[],CHEMBL1909182,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL233,Homo sapiens,Mu opioid receptor,9606.0,,,Ki,,,,
113577,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712490,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113578,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712491,[],CHEMBL1909183,DRUGMATRIX: Phorbol Ester radioligand binding (ligand: [3H] PDBu),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113579,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712492,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113580,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712493,[],CHEMBL1909184,DRUGMATRIX: Phosphodiesterase PDE3 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113581,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712494,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113582,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712495,[],CHEMBL1909185,DRUGMATRIX: Phosphodiesterase PDE4 enzyme inhibition (substrate: [3H]cAMP + cAMP),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113583,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712496,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,IC50,,,,
113584,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712497,[],CHEMBL1909186,DRUGMATRIX: Phosphodiesterase PDE5 enzyme inhibition (substrate: [3H]cGMP + cGMP),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1827,Homo sapiens,Phosphodiesterase 5A,9606.0,,,Ki,,,,
113585,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712498,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,IC50,,,,
113586,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712499,[],CHEMBL1909187,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL250,Homo sapiens,Platelet activating factor receptor,9606.0,,,Ki,,,,
113587,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712500,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113588,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712501,[],CHEMBL1909188,DRUGMATRIX: Platelet-Derived Growth Factor (PDGF) radioligand binding (ligand: [125I] PDGF),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113589,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712502,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113590,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712503,[],CHEMBL1909189,DRUGMATRIX: Potassium Channel [KATP] radioligand binding (ligand: [3H] Glyburide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113591,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712504,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,IC50,,,,
113592,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712505,[],CHEMBL1909190,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL240,Homo sapiens,HERG,9606.0,,,Ki,,,,
113593,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712506,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,IC50,,,,
113594,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712507,[],CHEMBL1909191,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1909044,Bos taurus,Progesterone receptor,9913.0,,,Ki,,,,
113595,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712508,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,IC50,,,,
113596,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712509,[],CHEMBL1909192,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4074,Oryctolagus cuniculus,Angiotensin-converting enzyme,9986.0,,,Ki,,,,
113597,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712510,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,IC50,,,,
113598,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712511,[],CHEMBL1909193,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4801,Homo sapiens,Caspase-1,9606.0,,,Ki,,,,
113599,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712512,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,IC50,,,,
113600,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712513,[],CHEMBL1909194,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4071,Homo sapiens,Cathepsin G,9606.0,,,Ki,,,,
113601,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712514,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,IC50,,,,
113602,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712515,[],CHEMBL1909195,"DRUGMATRIX: Peptidase, ELA2 (Neutrophil Elastase 2) enzyme inhibition (substrate: N-MeOSuc-Ala-Ala-Pro-Val-pNA)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL248,Homo sapiens,Leukocyte elastase,9606.0,,,Ki,,,,
113603,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712516,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,IC50,,,,
113604,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712517,[],CHEMBL1909196,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL332,Homo sapiens,Matrix metalloproteinase-1,9606.0,,,Ki,,,,
113605,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712518,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,IC50,,,,
113606,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712519,[],CHEMBL1909197,"DRUGMATRIX: Protease, Matrix Metalloprotease-9 (MMP-9) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL321,Homo sapiens,Matrix metalloproteinase 9,9606.0,,,Ki,,,,
113607,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712520,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,IC50,,,,
113608,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712521,[],CHEMBL1909198,DRUGMATRIX: Protein Serine/Threonine Kinase PKCalpha enzyme inhibition (substrate: Histone),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL299,Homo sapiens,Protein kinase C alpha,9606.0,,,Ki,,,,
113609,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712522,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,IC50,,,,
113610,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712523,[],CHEMBL1909199,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3385,Homo sapiens,MAP kinase ERK1,9606.0,,,Ki,,,,
113611,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712524,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,IC50,,,,
113612,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712525,[],CHEMBL1909200,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4040,Homo sapiens,MAP kinase ERK2,9606.0,,,Ki,,,,
113613,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712526,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,IC50,,,,
113614,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712527,[],CHEMBL1909201,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL260,Homo sapiens,MAP kinase p38 alpha,9606.0,,,Ki,,,,
113615,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712528,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,IC50,,,,
113616,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712529,[],CHEMBL1909202,"DRUGMATRIX: Protein Serine/Threonine Phosphatase, PPP3CA (Calcineurin, PP2B) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL4445,Homo sapiens,"Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform",9606.0,,,Ki,,,,
113617,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712530,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,IC50,,,,
113618,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712531,[],CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL203,Homo sapiens,Epidermal growth factor receptor erbB1,9606.0,,,Ki,,,,
113619,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712532,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,IC50,,,,
113620,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712533,[],CHEMBL1909204,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1841,Homo sapiens,Tyrosine-protein kinase FYN,9606.0,,,Ki,,,,
113621,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712534,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,IC50,,,,
113622,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712535,[],CHEMBL1909205,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1824,Homo sapiens,Receptor protein-tyrosine kinase erbB-2,9606.0,,,Ki,,,,
113623,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712536,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,IC50,,,,
113624,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712537,[],CHEMBL1909206,"DRUGMATRIX: Protein Tyrosine Kinase, LCK enzyme inhibition (substrate: Poly(Glu:Tyr))",B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL258,Homo sapiens,Tyrosine-protein kinase LCK,9606.0,,,Ki,,,,
113625,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712538,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000190,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,IC50,,,,
113626,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712539,[],CHEMBL1909207,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",B,,,BAO_0000192,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3243,Homo sapiens,Leukocyte common antigen,9606.0,,,Ki,,,,
113627,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712540,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113628,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712541,[],CHEMBL1909208,"DRUGMATRIX: Purinergic P2X radioligand binding (ligand: [3H] alpha, beta-Methylene-ATP)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113629,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712542,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,IC50,,,,
113630,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712543,[],CHEMBL1909209,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL273,Rattus norvegicus,Serotonin 1a (5-HT1a) receptor,10116.0,,,Ki,,,,
113631,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712544,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,IC50,,,,
113632,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712545,[],CHEMBL1909210,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3459,Rattus norvegicus,Serotonin 1b (5-HT1b) receptor,10116.0,,,Ki,,,,
113633,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712546,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,IC50,,,,
113634,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712547,[],CHEMBL1909211,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL224,Homo sapiens,Serotonin 2a (5-HT2a) receptor,9606.0,,,Ki,,,,
113635,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712548,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,IC50,,,,
113636,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712549,[],CHEMBL1909104,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1833,Homo sapiens,Serotonin 2b (5-HT2b) receptor,9606.0,,,Ki,,,,
113637,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712550,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,IC50,,,,
113638,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712551,[],CHEMBL1909105,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL225,Homo sapiens,Serotonin 2c (5-HT2c) receptor,9606.0,,,Ki,,,,
113639,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712552,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113640,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712553,[],CHEMBL1909106,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT3 radioligand binding (ligand: [3H] GR-65630),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113641,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712554,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,IC50,,,,
113642,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712555,[],CHEMBL1909107,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL5017,Cavia porcellus,Serotonin 4 (5-HT4) receptor,10141.0,,,Ki,,,,
113643,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712556,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,IC50,,,,
113644,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712557,[],CHEMBL1909108,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT6 radioligand binding (ligand: [3H] Lysergic acid diethylamide),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3371,Homo sapiens,Serotonin 6 (5-HT6) receptor,9606.0,,,Ki,,,,
113645,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712558,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,IC50,,,,
113646,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712559,[],CHEMBL1909109,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL228,Homo sapiens,Serotonin transporter,9606.0,,,Ki,,,,
113647,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712560,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,IC50,,,,
113648,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712561,[],CHEMBL1909110,DRUGMATRIX: Sigma1 radioligand binding (ligand: [3H] Haloperidol),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL287,Homo sapiens,Sigma opioid receptor,9606.0,,,Ki,,,,
113649,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712562,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113650,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712563,[],CHEMBL1909111,DRUGMATRIX: Sigma2 radioligand binding (ligand: [3H] Ifenprodil),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113651,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712564,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113652,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712565,[],CHEMBL1909112,"DRUGMATRIX: Sodium Channel, Site 2 radioligand binding (ligand: [3H] Batrachotoxin)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113653,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712566,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,IC50,,,,
113654,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712567,[],CHEMBL1909113,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL249,Homo sapiens,Neurokinin 1 receptor,9606.0,,,Ki,,,,
113655,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712568,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,IC50,,,,
113656,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712569,[],CHEMBL1909114,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL2327,Homo sapiens,Neurokinin 2 receptor,9606.0,,,Ki,,,,
113657,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712570,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,IC50,,,,
113658,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712571,[],CHEMBL1909115,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL3072,Rattus norvegicus,Androgen Receptor,10116.0,,,Ki,,,,
113659,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712572,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000190,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,IC50,,,,
113660,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712573,[],CHEMBL1909116,DRUGMATRIX: Thromboxane Synthetase enzyme inhibition (substrate: PGH2),B,,,BAO_0000192,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1835,Homo sapiens,Thromboxane-A synthase,9606.0,,,Ki,,,,
113661,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712574,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL612545,,Unchecked,,,,IC50,,,,
113662,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712575,[],CHEMBL1909117,"DRUGMATRIX: Tumor Necrosis Factor (TNF), Non-Selective radioligand binding (ligand: [125I] TNF-alpha)",B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL612545,,Unchecked,,,,Ki,,,,
113663,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712576,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,IC50,,,,
113664,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712577,[],CHEMBL1909118,DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF),B,,,BAO_0000192,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1868,Homo sapiens,Vascular endothelial growth factor receptor 1,9606.0,,,Ki,,,,
113665,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712578,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,IC50,,,,
113666,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712579,[],CHEMBL1909119,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL5144,Homo sapiens,Vasoactive intestinal polypeptide receptor 1,9606.0,,,Ki,,,,
113667,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712580,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000190,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,IC50,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,IC50,,,,
113668,,Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured),7712581,[],CHEMBL1909120,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),B,,,BAO_0000192,BAO_0000249,cell membrane format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909046,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1539631,,15,0,,,Ki,,,,CHEMBL1889,Homo sapiens,Vasopressin V1a receptor,9606.0,,,Ki,,,,
113669,,,7837907,[],CHEMBL1909307,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_bilirubinemia,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_bilirubinemia,,,,0.0
113670,,,7837908,[],CHEMBL1909308,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_cholecystitis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholecystitis,,,,0.0
113671,,,7837909,[],CHEMBL1909309,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_cholelithiasis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cholelithiasis,,,,0.0
113672,,,7837910,[],CHEMBL1909310,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_cirrhosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_cirrhosis,,,,0.0
113673,,,7837911,[],CHEMBL1909311,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_elevated liver function tests,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_elevated liver function tests,,,,0.0
113674,,,7837912,[],CHEMBL1909312,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_hepatic failure,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic failure,,,,1.0
113675,,,7837913,[],CHEMBL1909313,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_hepatic necrosis,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatic necrosis,,,,0.0
113676,,,7837914,[],CHEMBL1909314,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_hepatitis,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatitis,,,,1.0
113677,,,7837915,[],CHEMBL1909315,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_hepatomegaly,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_hepatomegaly,,,,1.0
113678,,,7837916,[],CHEMBL1909316,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_jaundice,,,1.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_jaundice,,,,1.0
113679,,,7837917,[],CHEMBL1909317,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_liver disease,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver disease,,,,0.0
113680,,,7837918,[],CHEMBL1909318,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_liver fatty,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver fatty,,,,0.0
113681,,,7837919,[],CHEMBL1909319,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_liver function tests abnormal,,,0.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_liver function tests abnormal,,,,0.0
113682,,,7837920,[],CHEMBL1909320,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,A,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1909294,PLoS Comput Biol,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1540787,=,1,0,=,,HepSE_Combined Scores,,,4.0,CHEMBL1697861,,Hepatotoxicity,,,,HepSE_Combined Scores,,,,4.0
113683,,,7973861,[],CHEMBL1930268,Antibacterial activity against erythromycin-sensitive Staphylococcus aureus ATCC 13709 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
113684,,,7973876,[],CHEMBL1930269,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae SP030 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
113685,,,7973898,[],CHEMBL1930270,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes 3565 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
113686,,,7973922,[],CHEMBL1930271,"Antibacterial activity against inducible macrolide, licosamide and streptogramin-resistant Staphylococcus aureus 90256/97 by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113687,,,7973944,[],CHEMBL1930272,"Antibacterial activity against inducible macrolide-resistant, constitutive licosamide and streptogramin-resistant Streptococcus pneumoniae 134 GR-Micro by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
113688,,,7973976,[],CHEMBL1930273,"Antibacterial activity against inducible macrolide, licosamide and streptogramin-resistant Streptococcus pyogenes Finland 11 by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.0
113689,,,7974006,[],CHEMBL1930274,"Antibacterial activity against constitutive macrolide, licosamide and streptogramin-resistant Staphylococcus aureus PK2 by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113690,,,7974012,[],CHEMBL1930275,"Antibacterial activity against constitutive macrolide, licosamide and streptogramin-resistant Streptococcus pneumoniae 58 Spain by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
113691,,,7974030,[],CHEMBL1930276,"Antibacterial activity against constitutive macrolide, licosamide and streptogramin-resistant Streptococcus pyogenes 166 GR-Micro by broth microdilution technique",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,64.0
113692,,,7974072,[],CHEMBL1930277,Antibacterial activity against efflux-mediated macrolide-resistant Staphylococcus aureus PK1 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113693,,,7974085,[],CHEMBL1930278,Antibacterial activity against efflux-mediated macrolide-resistant Streptococcus pneumoniae Ci137 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113694,,,7974102,[],CHEMBL1930279,Antibacterial activity against efflux-mediated macrolide-resistant Streptococcus pyogenes 3 Finland by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113695,,,7975268,[],CHEMBL1930280,Antibacterial activity against Haemophilus influenzae ATCC 49247 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
113696,,,7975290,[],CHEMBL1930281,Antibacterial activity against Moraxella catarrhalis ATCC 23246 by broth microdilution technique,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1926518,Bioorg Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1564214,<=,1,1,<=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
113697,,,7983017,[],CHEMBL1937644,Antibacterial activity against Streptococcus pneumoniae by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
113698,,,7983047,[],CHEMBL1937645,Antibacterial activity against Streptococcus pneumoniae 6303 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.25
113699,,,7983079,[],CHEMBL1937646,Antibacterial activity against Streptococcus pneumoniae 49619 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
113700,,,7983111,[],CHEMBL1937647,Antibacterial activity against Streptococcus pneumoniae 3579 expressing erm gene by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113701,,,7983143,[],CHEMBL1936381,Antibacterial activity against Streptococcus pneumoniae 994 expressing mef gene by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.5
113702,,,7983175,[],CHEMBL1936382,Antibacterial activity against Streptococcus pyogenes 19615 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
113703,,,7983207,[],CHEMBL1936383,Antibacterial activity against Haemophilus influenzae 38 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,>,1,1,>,,MIC,ug.mL-1,,16.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,16.0
113704,,,7983829,[],CHEMBL1936384,Antibacterial activity against Moraxella catarrhalis 8176 by NCCLS method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1933046,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1567180,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,4.0
113705,,Not Determined,8008960,[],CHEMBL1944237,Antimycobacterial activity against Mycobacterium bovis BCG assessed as growth inhibition at 0.5 to 100 ug/ml by microplate alamar blue assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1938355,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1570362,,1,0,,,GI,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,,,,
113706,,Not Determined,8008979,[],CHEMBL1942705,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as growth inhibition at 0.5 to 100 ug/ml by microplate alamar blue assay,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1938355,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1570362,,1,0,,,GI,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,,,,
113707,,,8008988,[],CHEMBL1942709,Antimycobacterial activity against Mycobacterium avium ATCC 25291 assessed as growth inhibition at 2 ug/ml by microplate alamar blue assay,F,,,BAO_0000096,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1938355,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1570362,=,1,0,=,,GI,%,,100.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,GI,%,UO_0000187,,100.0
113708,,,8027296,[],CHEMBL1947501,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.032
113709,,,8027323,[],CHEMBL1947502,"Antibacterial activity against penicillin-, constitutive MLS-resistant Streptococcus pneumoniae PU 11 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
113710,,,8027350,[],CHEMBL1947503,"Antibacterial activity against efflux,penicillin-susceptible Streptococcus pneumoniae PU 09 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113711,,,8027377,[],CHEMBL1947558,"Antibacterial activity against penicillin-susceptible, constitutive MLS-resistant Streptococcus pneumoniae PU 27 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113712,,,8027404,[],CHEMBL1947559,"Antibacterial activity against efflux, erythromycin-resistant Streptococcus dysgalactiae A 1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL1075341,Streptococcus dysgalactiae,Streptococcus dysgalactiae,1334.0,,,MIC,ug ml-1,UO_0000274,,8.0
113713,,,8027416,[],CHEMBL1947560,Antibacterial activity against constitutive MLS-resistant Streptococcus pyogenes A 2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,256.0
113714,,,8027428,[],CHEMBL1947561,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes A 3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.032
113715,,,8027440,[],CHEMBL1947562,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
113716,,,8027452,[],CHEMBL1947563,"Antibacterial activity against methicillin-, inducible MLS-resistant erythromycin-susceptible Staphylococcus aureus PU 32 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
113717,,,8027464,[],CHEMBL1947564,"Antibacterial activity against methicillin-, constitutive MLS-resistant erythromycin-susceptible Staphylococcus aureus PU 20 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113718,,,8027476,[],CHEMBL1947565,"Antibacterial activity against methicillin-susceptible, inducible MLS-resistant Staphylococcus aureus PU 64 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
113719,,,8027488,[],CHEMBL1947566,"Antibacterial activity against methicillin-resistant, coagulase-negative, constitutive MLS-resistant Staphylococcus haemolyticus PU 19 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,256.0
113720,,,8027500,[],CHEMBL1947567,"Antibacterial activity against methicillin-susceptible, inducible MLS-resistant Staphylococcus epidermidis E1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113721,,,8028083,[],CHEMBL1947568,"Antibacterial activity against methicillin-resistant, constitutive MLS-resistant Staphylococcus epidermidis E2 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113722,,,8028095,[],CHEMBL1947569,"Antibacterial activity against methicillin-resistant, coagulase-negative, inducible MLS-resistant Staphylococcus hominis E3 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1944546,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1576740,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,256.0
113723,,,10870965,[],CHEMBL2025006,Antibacterial activity against Staphylococcus aureus ATCC 13709 after 24 hrs at 37 degC by CLSI protocol based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2021818,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1638089,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
113724,,,10870966,[],CHEMBL2025007,Antibacterial activity against Streptococcus pneumoniae ATCC 149619 after 24 hrs at 37 degC by CLSI protocol based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2021818,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1638089,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
113725,,,10870967,[],CHEMBL2025008,Antibacterial activity against Streptococcus pyogenes ATCC 700294 after 24 hrs at 37 degC by CLSI protocol based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2021818,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1638089,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.125
113726,,,10870968,[],CHEMBL2025009,Antibacterial activity against Moraxella catarrhalis ATCC 23246 after 24 hrs at 37 degC by CLSI protocol based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2021818,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1638089,<,1,1,<,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
113727,,,10870969,[],CHEMBL2025010,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 24 hrs at 37 degC by CLSI protocol based microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2021818,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1638089,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,8.0
113728,,Not Determined,10934676,[],CHEMBL2050201,Antimycobacterial activity against Mycobacterium bovis BCG assessed as inhibition of microbial growth at 0.5 to 100 ug/ml incubated for 6 days by MABA method,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2046352,Bioorg Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1654106,,1,0,,,GI,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,,,,
113729,,Not Determined,10934677,[],CHEMBL2050207,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of microbial growth at 0.5 to 100 ug/ml incubated for 6 days by MABA method,F,,,BAO_0000181,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2046352,Bioorg Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1654106,,1,0,,,GI,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,GI,,,,
113730,,,10934678,[],CHEMBL2050332,Antimycobacterial activity against Mycobacterium avium ATCC 25291 assessed as inhibition of microbial growth at 2 ug/ml incubated for 6 days by MABA method,F,,,BAO_0000096,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2046352,Bioorg Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1654106,=,1,0,=,,GI,%,,100.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,GI,%,UO_0000187,,100.0
113731,,,10982302,[],CHEMBL2066873,Antibacterial activity against eryhtromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2062383,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658812,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113732,,,10982307,[],CHEMBL2066874,Antibacterial activity against Streptococcus pneumoniae 210 expressing mefA efflux pump by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2062383,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658812,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
113733,,,10982312,[],CHEMBL2066875,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 205 expressing ermB ribosomal methylase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2062383,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658812,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113734,,,10982317,[],CHEMBL2066876,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 1104 expressing ermB ribosomal methylase by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2062383,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658812,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,128.0
113735,,,10982322,[],CHEMBL2066877,Antibacterial activity against Haemophilus influenzae ATCC 43095 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2062383,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658812,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
113736,,Active,10983323,[],CHEMBL2071965,Inhibition of human CYP2D6 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 4-methylaminoethyl-7-methoxycoumarin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1663544,,1,0,,,Inhibition,%,,,CHEMBL289,Homo sapiens,Cytochrome P450 2D6,9606.0,,,INH,,UO_0000187,,
113737,,Active,10984155,[],CHEMBL2071964,Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1663544,,1,0,,,Inhibition,%,,,CHEMBL3622,Homo sapiens,Cytochrome P450 2C19,9606.0,,,INH,,UO_0000187,,
113738,,Active,10984978,[],CHEMBL2071963,Inhibition of human CYP2C9 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-methoxy-4-trifluoromethylcoumarin-3-acetic acid as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1663544,,1,0,,,Inhibition,%,,,CHEMBL3397,Homo sapiens,Cytochrome P450 2C9,9606.0,,,INH,,UO_0000187,,
113739,,Active,10985199,[],CHEMBL2071962,Inhibition of human CYP1A2 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using ethoxyresorufin as substrate after 30 mins,A,,,BAO_0000201,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1663544,,1,0,,,Inhibition,%,,,CHEMBL3356,Homo sapiens,Cytochrome P450 1A2,9606.0,,,INH,,UO_0000187,,
113740,,Not Determined,10994292,[],CHEMBL2071972,Covalent binding affinity to human liver microsomes assessed per mg of protein at 10 uM after 60 mins presence of NADPH,A,,,BAO_0000375,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1663544,,1,0,,,Activity,,,,CHEMBL613373,Homo sapiens,Liver microsomes,9606.0,,,Activity,,,,
113741,,Stable,10995339,[],CHEMBL2071971,Metabolic stability in human liver microsomes assessed as GSH adduct formation at 100 uM after 90 mins by HPLC-MS analysis,A,,,BAO_0000179,BAO_0000251,microsome format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1663544,,1,0,,,Stability,%,,,CHEMBL613373,Homo sapiens,Liver microsomes,9606.0,,,Stability,,UO_0000187,,
113742,,,10996464,[],CHEMBL2071967,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 7-benzyloxyquinoline as substrate after 30 mins,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1663544,>,1,0,>,,Ratio IC50,,,5.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ratio IC50,,,,5.0
113743,,,10996685,[],CHEMBL2071966,Inhibition of human CYP3A4 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using diethoxyfluorescein as substrate after 30 mins,A,,,BAO_0000179,BAO_0000357,single protein format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2069259,Chem Res Toxicol,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1663544,>,1,0,>,,Ratio IC50,,,5.0,CHEMBL340,Homo sapiens,Cytochrome P450 3A4,9606.0,,,Ratio IC50,,,,5.0
113744,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [(at a rough estimate) 820 % of control],10996998,[],CHEMBL2076935,"TP_TRANSPORTER: inhibition of Cyclosporin A efflux (CsA: 0.005 uM, Clarithromycin: 100 uM) in P388/S and P388/ADR cells",F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2073923,Clin Exp Pharmacol Physiol,2000.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1672758,,18,0,,,Activity,,,,CHEMBL2573,Mus musculus,P-glycoprotein 3,10090.0,,,Activity,,,,
113745,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [+],10997588,[],CHEMBL2077012,TP_TRANSPORTER: transepithelial transport of digoxin (apical to basal) (Digoxin: 20-30uM) in MDR1-expressing LLC-GA5-COL150 cell,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2073837,Drug Metab Dispos,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1669364,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
113746,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",substrate [+],10997681,[],CHEMBL2076109,TP_TRANSPORTER: transepithelial transport in MDR1-expressing MDCK cells,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074144,J Pharmacol Exp Ther,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1669637,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
113747,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",substrate [+],10997717,[],CHEMBL2076217,TP_TRANSPORTER: transepithelial transport (basal to apical) in MDR1-expressing MDCKII cells,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1671573,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
113748,"{'action_type': 'SUBSTRATE', 'description': 'Carried by a transporter, possibly competing with the natural substrate for transport', 'parent_type': 'OTHER'}",substrate [+],10997771,[],CHEMBL2076219,TP_TRANSPORTER: ATP hydrolysis in MDR1-expressing Sf9 cells,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1671573,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
113749,,inhibitor [],10998834,[],CHEMBL2077492,TP_TRANSPORTER: inhibition of theophylline uptake in OAT2-expressing oocytes,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074379,Drug Metab Dispos,2005.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1672576,,18,0,,,Activity,,,,CHEMBL1955711,Homo sapiens,Solute carrier family 22 member 7,9606.0,,,Activity,,,,
113750,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=15.1uM],11001012,[],CHEMBL2076213,TP_TRANSPORTER: inhibition of Rhodamine 123 efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.82,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,15100.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,15.1
113751,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=23.8uM],11001356,[],CHEMBL2078544,TP_TRANSPORTER: inhibition of Tetramethylrosamine efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.62,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,23800.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,23.8
113752,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=3.8uM],11001419,[],CHEMBL2076218,TP_TRANSPORTER: inhibition of Daunorubicin efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,5.42,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,3800.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,3.8
113753,,is not an inhibitor [-],11001563,[],CHEMBL2076208,TP_TRANSPORTER: inhibition of Calcein-AM efflux in MDR1-expressing MDCKII cells,F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1908284,J Pharmacol Exp Ther,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1671573,,18,0,,,Activity,,,,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,Activity,,,,
113754,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=50.2uM],11001776,[],CHEMBL2078545,TP_TRANSPORTER: inhibition of JC-1 efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.3,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,50200.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,50.2
113755,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=56.1uM],11001792,[],CHEMBL2078547,TP_TRANSPORTER: inhibition of Calcein-AM efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.25,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,56100.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,56.1
113756,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=7.2uM],11001841,[],CHEMBL2076214,TP_TRANSPORTER: inhibition of LDS-751 efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,5.14,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,7200.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,7.2
113757,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [IC50=86.7uM],11001887,[],CHEMBL2078546,TP_TRANSPORTER: inhibition of Fluo-3-AM efflux in NIH-3T3-G185 cells,F,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2074145,Biochem Biophys Res Commun,2001.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,4.06,0,http://www.openphacts.org/units/Nanomolar,1671819,=,18,1,=,,IC50,nM,,86700.0,CHEMBL4302,Homo sapiens,P-glycoprotein 1,9606.0,,,IC50,uM,UO_0000065,,86.7
113758,"{'action_type': 'INHIBITOR', 'description': 'Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway', 'parent_type': 'NEGATIVE MODULATOR'}",inhibitor [(at a rough estimate) 250 % of control],11003073,[],CHEMBL2076927,"TP_TRANSPORTER: inhibition of Vinblastine efflux (Vinblastine: 0.002 uM, Clarithromycin: 100 uM) in P388/S and P388/ADR cells",F,,,BAO_0000375,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2073923,Clin Exp Pharmacol Physiol,2000.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1672758,,18,0,,,Activity,,,,CHEMBL2573,Mus musculus,P-glycoprotein 3,10090.0,,,Activity,,,,
113759,,inconclusive,11295607,[],CHEMBL2114843,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1211178,,7,1,,,Potency,nM,,11582.1,CHEMBL1293278,Homo sapiens,Geminin,9606.0,,,Potency,uM,UO_0000065,,11.5821
113760,,inactive,11453068,[],CHEMBL2114775,PubChem BioAssay. qHTS Assay for Inhibitors of Hepatitis C Virus (HCV). (Class of assay: confirmatory) ,F,,,BAO_0000186,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL1201862,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,1211178,,7,1,,,Potency,nM,,35481.3,CHEMBL612545,,Unchecked,,,,Potency,uM,UO_0000065,,35.4813
113761,,,12043319,[],CHEMBL2148743,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2146424,Bioorg Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727703,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113762,,,12043320,[],CHEMBL2148744,Antibacterial activity against MLSB-resistant Streptococcus pneumoniae 205 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2146424,Bioorg Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1727703,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113763,,,12084241,[],CHEMBL2167494,Antimicrobial activity against Helicobacter pylori 26695 ATCC 700392 at 50 ug/ml by disk agar diffusion method,F,,,BAO_0003039,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2163213,Eur J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Millimeter,1738917,=,1,1,=,,IZ,mm,,21.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,DIZ,mm,UO_0000016,,21.0
113764,,,12089744,[],CHEMBL2169431,Inhibition of human liver OATP2B1 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E3S uptake at 20 uM incubated for 5 mins by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1737328,=,1,1,=,,Inhibition,%,,5.1,CHEMBL1743124,Homo sapiens,Solute carrier organic anion transporter family member 2B1,9606.0,,,INH,%,UO_0000187,,5.1
113765,,,12090556,[],CHEMBL2169430,Inhibition of human liver OATP1B3 expressed in HEK293 Flp-In cells assessed as reduction in [3H]E17-betaG uptake at 20 uM incubated for 5 mins by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1737328,=,1,1,=,,Inhibition,%,,53.8,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,INH,%,UO_0000187,,53.8
113766,,,12091668,[],CHEMBL2169429,Inhibition of human liver OATP1B1 expressed in HEK293 Flp-In cells assessed as reduction in E17-betaG uptake at 20 uM by scintillation counting,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2163248,J Med Chem,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1737328,=,1,1,=,,Inhibition,%,,73.1,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,INH,%,UO_0000187,,73.1
113767,,,12142904,[],CHEMBL2184180,Cellular uptake in human NHBE assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,0.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,0.0
113768,,,12142934,[],CHEMBL2184176,Cellular uptake in normal human lung fibroblast at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,127.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,127.0
113769,,,12142940,[],CHEMBL2184175,Cellular uptake in human MDM at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,66.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,66.0
113770,,,12142941,[],CHEMBL2184177,Cellular uptake in human BSMC at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,36.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,36.0
113771,,,12142971,[],CHEMBL2184178,Cellular uptake in human NHBE at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,25.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,25.0
113772,,,12142972,[],CHEMBL2184179,Cellular uptake in human PMNC at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,36.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,36.0
113773,,,12142979,[],CHEMBL2184173,Cellular uptake in human T NCI-H292 cells at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,35.0,CHEMBL614733,Homo sapiens,NCI-H292,9606.0,,,Drug uptake,%,UO_0000187,,35.0
113774,,,12142983,[],CHEMBL2184172,Cellular uptake in human PMNC assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,2.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,2.0
113775,,,12142988,[],CHEMBL2184167,Cellular uptake in human NCI-H292 cells assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,1.0,CHEMBL614733,Homo sapiens,NCI-H292,9606.0,,,Drug uptake,%,UO_0000187,,1.0
113776,,,12142990,[],CHEMBL2184169,Cellular uptake in human MDM assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,4.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,4.0
113777,,,12142991,[],CHEMBL2184170,Cellular uptake in normal human lung fibroblasts assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,1.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,1.0
113778,,,12142993,[],CHEMBL2184174,Cellular uptake in human T lymphocytes at 3 to 20 uM after 3 hrs by by LC-MS/MS analysis relative to azithromycin,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,16.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,16.0
113779,,,12142998,[],CHEMBL2184168,Cellular uptake in human T lymphocytes assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,2.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,2.0
113780,,,12143000,[],CHEMBL2184171,Cellular uptake in human BSMC assessed as compound retention at 3 to 20 uM incubated for 3 hrs followed by drug washout measured after 3 hrs by LC-MS/MS analysis relative to initial drug accumulation,A,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2177068,J Med Chem,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1752542,=,1,0,=,,Drug uptake,%,,1.0,CHEMBL612558,,ADMET,,,,Drug uptake,%,UO_0000187,,1.0
113781,,,12189354,[],CHEMBL2216158,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 09Q149 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,32.0
113782,,,12189355,[],CHEMBL2216159,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes 09U070 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.031,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.031
113783,,,12189356,[],CHEMBL2216592,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 09E427 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
113784,,,12189357,[],CHEMBL2216593,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 09D016 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
113785,,,12189358,[],CHEMBL2216594,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 09H071 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.062
113786,,,12189359,[],CHEMBL2216595,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 09H065 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.062
113787,,,12189360,[],CHEMBL2216596,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.125
113788,,,12189361,[],CHEMBL2216597,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09M124 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
113789,,,12189362,[],CHEMBL2216598,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09R476 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.25
113790,,,12189363,[],CHEMBL2216599,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09G291 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
113791,,,12189364,[],CHEMBL2216600,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09A011 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.125
113792,,,12189365,[],CHEMBL2216601,Antibacterial activity against methicillin-resistant Staphylococcus aureus 09N120 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113793,,,12189366,[],CHEMBL2216602,Antibacterial activity against methicillin-resistant Staphylococcus aureus 09L075 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
113794,,,12189367,[],CHEMBL2216603,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 09U035 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113795,,,12189368,[],CHEMBL2216604,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 09O077 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113796,,,12189369,[],CHEMBL2216605,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2203277,Bioorg Med Chem Lett,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1758650,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
113797,,,12582286,[],CHEMBL3075814,Antibacterial activity against Helicobacter pylori assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC90,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC90,ug ml-1,UO_0000274,,128.0
113798,,,12582294,[],CHEMBL3075814,Antibacterial activity against Helicobacter pylori assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC50,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC50,ug ml-1,UO_0000274,,128.0
113799,,,12582362,[],CHEMBL3072723,Antibacterial activity against Helicobacter pylori 06-8 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113800,,,12582370,[],CHEMBL3072724,Antibacterial activity against Helicobacter pylori 06-7 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113801,,,12582378,[],CHEMBL3074372,Antibacterial activity against Helicobacter pylori 06-6 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113802,,,12582386,[],CHEMBL3074373,Antibacterial activity against Helicobacter pylori 06-5 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113803,,,12582394,[],CHEMBL3074374,Antibacterial activity against Helicobacter pylori 06-4 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113804,,,12582402,[],CHEMBL3074375,Antibacterial activity against Helicobacter pylori 06-3 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113805,,,12582410,[],CHEMBL3074376,Antibacterial activity against Helicobacter pylori 06-2 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113806,,,12582418,[],CHEMBL3074377,Antibacterial activity against Helicobacter pylori 06-1 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,64.0
113807,,,12582426,[],CHEMBL3074378,Antibacterial activity against Helicobacter pylori 05-3 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,64.0
113808,,,12582434,[],CHEMBL3074084,Antibacterial activity against Helicobacter pylori 05-14 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113809,,,12582442,[],CHEMBL3074085,Antibacterial activity against Helicobacter pylori 05-12 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113810,,,12582450,[],CHEMBL3074086,Antibacterial activity against Helicobacter pylori 05-9 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113811,,,12582458,[],CHEMBL3074087,Antibacterial activity against Helicobacter pylori 05-5 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113812,,,12582466,[],CHEMBL3074088,Antibacterial activity against Helicobacter pylori 05-4 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113813,,,12582474,[],CHEMBL3074089,Antibacterial activity against Helicobacter pylori 05-2 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,64.0
113814,,,12583062,[],CHEMBL3074090,Antibacterial activity against Helicobacter pylori 05-1 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,128.0
113815,,,12583070,[],CHEMBL3074091,Antibacterial activity against Helicobacter pylori ATCC 11637 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC,ug ml-1,UO_0000274,,32.0
113816,,,12583079,[],CHEMBL3074092,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
113817,,,12583101,[],CHEMBL3074093,Antibacterial activity against Escherichia coli ATCC 25922 assessed as growth inhibition after 16 to 18 hr NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
113818,,,12583124,[],CHEMBL3074094,Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as growth inhibition after 16 to 18 hr by NCCLS agar dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3045868,Med Chem Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1837743,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
113819,,,12613051,[],CHEMBL2317073,"Antibacterial activity against methicillin-resistant, inducible MLS-resistant, coagulase-deficient Staphylococcus hominis E 3 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL614423,Staphylococcus hominis,Staphylococcus hominis,1290.0,,,MIC,ug ml-1,UO_0000274,,256.0
113820,,,12613068,[],CHEMBL2317074,"Antibacterial activity against methicillin-resistant, constitutive MLS-resistant Staphylococcus epidermidis E 2 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113821,,,12613085,[],CHEMBL2317075,"Antibacterial activity against methicillin-susceptible, inducible MLS-resistant Staphylococcus epidermidis E 1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113822,,,12613102,[],CHEMBL2317076,"Antibacterial activity against methicillin-resistant, constitutive MLS-resistant, coagulase-deficient Staphylococcus haemolyticus PU 19 expressing ermA gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL612507,Staphylococcus haemolyticus,Staphylococcus haemolyticus,1283.0,,,MIC,ug ml-1,UO_0000274,,256.0
113823,,,12613119,[],CHEMBL2317077,"Antibacterial activity against methicillin-sensitive, inducible MLS-resistant Staphylococcus aureus PU 64 expressing ermA gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,2.0
113824,,,12613136,[],CHEMBL2317078,"Antibacterial activity against methicillin-resistant, constitutive MLS-resistant Staphylococcus aureus PU 20 expressing ermC gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113825,,,12614592,[],CHEMBL2317079,"Antibacterial activity against methicillin-resistant, inducible MLS-resistant Staphylococcus aureus PU 32 expressing ermA gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
113826,,,12614609,[],CHEMBL2317080,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.25
113827,,,12614626,[],CHEMBL2317081,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes A3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.032
113828,,,12614643,[],CHEMBL2317082,Antibacterial activity against constitutive MLS-resistant Streptococcus pyogenes A2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,256.0
113829,,,12614660,[],CHEMBL2317083,Antibacterial activity against erythromycin-resistant Streptococcus dysgalactiae A1 expressing efflux pump by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL1075341,Streptococcus dysgalactiae,Streptococcus dysgalactiae,1334.0,,,MIC,ug ml-1,UO_0000274,,8.0
113830,,,12614677,[],CHEMBL2317084,"Antibacterial activity against penicillin-susceptible, constitutive MLS-resistant Streptococcus pneumoniae PU 27 expressing erm gene by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113831,,,12614694,[],CHEMBL2317085,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU 09 expressing mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113832,,,12614711,[],CHEMBL2317086,"Antibacterial activity against penicillin-resistant, constitutive MLS-resistant Streptococcus pneumoniae PU 11 expressing erm and mef genes by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
113833,,,12614728,[],CHEMBL2317087,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311404,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847239,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.032
113834,,,12620560,[],CHEMBL2317437,Antibacterial activity against Salmonella typhimurium TA102 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.25
113835,,,12620582,[],CHEMBL2317438,Antibacterial activity against Salmonella typhimurium TA98 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,,MIC,ug ml-1,UO_0000274,,0.5
113836,,,12622329,[],CHEMBL2317442,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes RE clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113837,,,12622351,[],CHEMBL2317443,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.03
113838,,,12622373,[],CHEMBL2317444,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
113839,,,12622395,[],CHEMBL2317445,Antibacterial activity against penicillin-resistant Staphylococcus aureus clinical isolate by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.03
113840,,,12622417,[],CHEMBL2317446,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.12,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.12
113841,,,12622439,[],CHEMBL2317447,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae AB11 expressing erm and mef genes by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,128.0
113842,,,12622461,[],CHEMBL2319369,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae A22072 expressing mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,4.0
113843,,,12622483,[],CHEMBL2319370,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae B1 expressing erm gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
113844,,,12622505,[],CHEMBL2319371,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2311450,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1847270,=,1,1,=,,MIC,ug.mL-1,,0.03,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.03
113845,,,12644239,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853502,>,1,1,>,,MIC90,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC90,ug ml-1,UO_0000274,,32.0
113846,,,12644240,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853502,>,1,1,>,,MIC80,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC80,ug ml-1,UO_0000274,,32.0
113847,,,12644241,[],CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2321831,J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853502,>,1,1,>,,MIC50,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC50,ug ml-1,UO_0000274,,32.0
113848,,,12693622,[],CHEMBL2343330,"Antibacterial activity against macrolides, lincosamides, streptogramin B and methicillin-resistant Staphylococcus aureus 1015-00 assessed as growth inhibition",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
113849,,,12693623,[],CHEMBL2340367,"Antibacterial activity against macrolides, lincosamides, streptogramin B and methicillin-resistant Staphylococcus aureus 1609-09 harboring cfr gene assessed as growth inhibition",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,16.0
113850,,,12693634,[],CHEMBL2340372,"Antibacterial activity against macrolides, lincosamides, streptogramin B and methicillin-resistant Staphylococcus epidermidis 1105-00 assessed as growth inhibition",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,mg/L,UO_0000274,,8.0
113851,,,12696373,[],CHEMBL2340371,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1279-07-USA300 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,1.0
113852,,,12696378,[],CHEMBL2343329,Antibacterial activity against Staphylococcus aureus ATCC 29213 assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
113853,,,12696382,[],CHEMBL2340368,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1279-07 harboring cfr gene assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
113854,,,12696387,[],CHEMBL2340370,Antibacterial activity against methicillin-resistant Staphylococcus aureus 2111-10-USA300 harboring cfr gene assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.5
113855,,,12696411,[],CHEMBL2340369,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1281-07 harboring cfr gene assessed as growth inhibition,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,mg/L,UO_0000274,,0.25
113856,,,12696427,[],CHEMBL2340373,"Antibacterial activity against macrolides, lincosamides, and streptogramin B-resistant Streptococcus pyogenes 1304-00 assessed as growth inhibition",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,mg/L,UO_0000274,,0.25
113857,,,12696440,[],CHEMBL2340374,"Antibacterial activity against macrolides, lincosamides, and streptogramin B-resistant Streptococcus pneumoniae 1243-00 assessed as growth inhibition",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331530,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1865458,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,mg/L,UO_0000274,,0.125
113858,,,12704798,[],CHEMBL2338843,"Antibacterial activity against methicillin-resistant, coagulase-negative, MLS-resistant (inducible) Staphylococcus epidermidis E3 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113859,,,12704812,[],CHEMBL2338844,"Antibacterial activity against methicillin-resistant, MLS-resistant (constitutive) Staphylococcus epidermidis E2 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113860,,,12704826,[],CHEMBL2338845,"Antibacterial activity against methicillin-susceptible, MLS-resistant (inducible) Staphylococcus epidermidis E1 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,256.0
113861,,,12704840,[],CHEMBL2338846,"Antibacterial activity against methicillin-resistant, coagulase-negative, MLS-resistant (constitutive) Staphylococcus aureus PU 19 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113862,,,12704849,[],CHEMBL2338847,"Antibacterial activity against methicillin-susceptible, MLS-resistant (inducible) Staphylococcus aureus PU 64 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113863,,,12704858,[],CHEMBL2338848,"Antibacterial activity against methicillin-resistant, MLS-resistant (constitutive) Staphylococcus aureus PU 20 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113864,,,12704872,[],CHEMBL2338849,"Antibacterial activity against methicillin-resistant, MLS-resistant (inducible) Staphylococcus aureus PU 32 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,256.0
113865,,,12704886,[],CHEMBL2338850,Antibacterial activity against erythromycin-susceptible Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
113866,,,12704900,[],CHEMBL2338851,Antibacterial activity against erythromycin-susceptible Streptococcus pyogenes A3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,<=,1,1,<=,,MIC,ug.mL-1,,0.008,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.008
113867,,,12704914,[],CHEMBL2338852,Antibacterial activity against MLS-resistant (constitutive) Streptococcus pyogenes A2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,256.0
113868,,,12707621,[],CHEMBL2338853,Antibacterial activity against erythromycin-resistant Streptococcus dysgalactiae A1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL1075341,Streptococcus dysgalactiae,Streptococcus dysgalactiae,1334.0,,,MIC,ug ml-1,UO_0000274,,16.0
113869,,,12707630,[],CHEMBL2338854,"Antibacterial activity against MLS-resistant (constitutive), penicillin-susceptible Streptococcus pneumoniae PU27 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
113870,,,12707644,[],CHEMBL2338856,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae PU09 harboring mef gene by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
113871,,,12707658,[],CHEMBL2338855,"Antibacterial activity against MLS-resistant (constitutive), penicillin-resistant Streptococcus pneumoniae PU11 by broth microdilution method",F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,>,1,1,>,,MIC,ug.mL-1,,256.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,256.0
113872,,,12707672,[],CHEMBL2338857,Antibacterial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2331130,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1871752,=,1,1,=,,MIC,ug.mL-1,,0.032,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.032
113873,,,13299330,[],CHEMBL2383067,Antibacterial activity against drug-resistant Pseudomonas aeruginosa by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,128.0
113874,,,13299331,[],CHEMBL2383068,Antibacterial activity against drug-resistant Salmonella typhi by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL614448,Salmonella enterica subsp. enterica serovar Typhi,Salmonella typhi,90370.0,,,MIC,ug ml-1,UO_0000274,,64.0
113875,,,13299332,[],CHEMBL2383069,Antibacterial activity against drug-resistant Klebsiella pneumoniae by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,,MIC,ug ml-1,UO_0000274,,64.0
113876,,,13299333,[],CHEMBL2383070,Antibacterial activity against drug-resistant Escherichia coli by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
113877,,,13299334,[],CHEMBL2383071,Antibacterial activity against drug-resistant Staphylococcus epidermidis by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
113878,,,13299335,[],CHEMBL2383072,Antibacterial activity against drug-resistant Staphylococcus aureus by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,>,1,1,>,,MIC,ug.mL-1,,128.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,128.0
113879,,,13299336,[],CHEMBL2383073,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,,MIC,ug ml-1,UO_0000274,,64.0
113880,,,13299337,[],CHEMBL2383074,Antibacterial activity against Escherichia coli ATCC 35218 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,32.0
113881,,,13299338,[],CHEMBL2383075,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,MIC,ug ml-1,UO_0000274,,64.0
113882,,,13299339,[],CHEMBL2383076,Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2380278,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1894373,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113883,,,13413524,[],CHEMBL2423183,Antibacterial activity against Mycobacterium avium assessed as growth inhibition at 2 ug/mL relative to control,F,,,BAO_0000096,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2417366,Bioorg Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1916056,=,1,0,=,,GI,%,,98.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,GI,%,UO_0000187,,98.0
113884,,,13487476,[],CHEMBL2438671,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 09-9 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
113885,,,13487485,[],CHEMBL2438927,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 09-3 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,64.0
113886,,,13487494,[],CHEMBL2438928,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,0.06
113887,,,13487503,[],CHEMBL2438929,Antibacterial activity against methicillin-resistant Staphylococcus aureus 09-13 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113888,,,13487512,[],CHEMBL2438930,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 09-6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
113889,,,13487521,[],CHEMBL2438931,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 15 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,=,1,1,=,,MIC,ug.mL-1,,0.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.5
113890,,,13487529,[],CHEMBL2438932,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33591 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113891,,,13487538,[],CHEMBL2438933,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2434850,Eur J Med Chem,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1924758,=,1,1,=,,MIC,ug.mL-1,,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.06
113892,,,13501720,[],CHEMBL2446540,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 12-6 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
113893,,,13501731,[],CHEMBL2446541,Antibacterial activity against erythromycin-resistant Streptococcus pneumoniae 12-5 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,32.0
113894,,,13501742,[],CHEMBL2446542,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-14 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113895,,,13501753,[],CHEMBL2446543,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-10 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113896,,,13501764,[],CHEMBL2446544,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-8 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113897,,,13502961,[],CHEMBL2446545,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
113898,,,13502972,[],CHEMBL2446546,Antibacterial activity against erythromycin-sensitive Streptococcus pneumoniae 12-1 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,1.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,1.0
113899,,,13502983,[],CHEMBL2446547,Antibacterial activity against erythromycin-resistant Streptococcus pyogenes 11-2 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113900,,,13502994,[],CHEMBL2446548,Antibacterial activity against erythromycin-sensitive Streptococcus pyogenes ATCC 19625 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,1.0
113901,,,13503005,[],CHEMBL2446549,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-11 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,4.0
113902,,,13503016,[],CHEMBL2446550,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-4 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,32.0
113903,,,13503027,[],CHEMBL2446551,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-5 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
113904,,,13503038,[],CHEMBL2446552,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 11-20 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,8.0
113905,,,13503049,[],CHEMBL2446553,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis ATCC 12228 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,,MIC,ug ml-1,UO_0000274,,1.0
113906,,,13503060,[],CHEMBL2446554,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-31 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,>,1,1,>,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113907,,,13503071,[],CHEMBL2446555,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-32 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,4.0
113908,,,13503082,[],CHEMBL2446556,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2440040,Bioorg Med Chem Lett,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1928125,<=,1,1,<=,,MIC,ug.mL-1,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,1.0
113909,,Basic pKa,13517664,[],CHEMBL2449007,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL2448811,Pharm Res,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1932855,,1,0,,,pKa,,,8.99,CHEMBL2362975,,No relevant target,,,,pKa,,,,8.99
113910,,,13798022,[],CHEMBL3039491,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1937377,=,1,1,=,,Inhibition,%,,80.47,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,Inhibition,%,UO_0000187,,80.47483711
113911,,,13798621,[],CHEMBL3039492,pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,5.48,0,http://www.openphacts.org/units/Nanomolar,1937377,=,1,1,=,,IC50,nM,,3311.31,CHEMBL1743121,Homo sapiens,Solute carrier organic anion transporter family member 1B3,9606.0,,,pIC50,,UO_0000065,,5.48
113912,,,13800036,[],CHEMBL3039488,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,A,,,BAO_0000201,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1937377,=,1,1,=,,Inhibition,%,,56.72,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,Inhibition,%,UO_0000187,,56.72378203
113913,,,13800620,[],CHEMBL3039489,pIC50 values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells,A,,,BAO_0000190,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3039007,Mol Pharmacol,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,5.51,0,http://www.openphacts.org/units/Nanomolar,1937377,=,1,1,=,,IC50,nM,,3090.3,CHEMBL1697668,Homo sapiens,Solute carrier organic anion transporter family member 1B1,9606.0,,,pIC50,,UO_0000065,,5.51
113914,,references out of a total of 58,13999392,[],CHEMBL3137722,"Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (moderate),,,47.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),,,,47.0
113915,,,13999393,[],CHEMBL3137723,"Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1979399,=,1,0,=,,Hepatotoxicity (moderate),%,,50.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (moderate),%,UO_0000187,,50.6
113916,,references out of a total of 58,13999394,[],CHEMBL3137724,"Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is number of references indexed. [column 'AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (acute),,,13.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (acute),,,,13.0
113917,,,13999395,[],CHEMBL3137725,"Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,1979399,=,1,0,=,,Hepatotoxicity (acute),%,,5.6,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (acute),%,UO_0000187,,5.6
113918,,references out of a total of 58,13999396,[],CHEMBL3137726,"Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (cytolytic),,,9.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cytolytic),,,,9.0
113919,,references out of a total of 58,13999397,[],CHEMBL3137727,"Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (choleostasis),,,6.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (choleostasis),,,,6.0
113920,,references out of a total of 58,13999398,[],CHEMBL3137728,"Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (severe hepatitis),,,4.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (severe hepatitis),,,,4.0
113921,,references out of a total of 58,13999399,[],CHEMBL3137729,"Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (chronic liver disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (chronic liver disease),,,,0.0
113922,,references out of a total of 58,13999400,[],CHEMBL3137730,"Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (cirrhosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (cirrhosis),,,,0.0
113923,,references out of a total of 58,13999401,[],CHEMBL3137731,"Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]",T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (granulomatous hepatitis),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (granulomatous hepatitis),,,,0.0
113924,,references out of a total of 58,13999402,[],CHEMBL3137732,"Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (association with vascular disease),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (association with vascular disease),,,,0.0
113925,,references out of a total of 58,13999403,[],CHEMBL3137733,"Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (steatosis),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (steatosis),,,,0.0
113926,,references out of a total of 58,13999404,[],CHEMBL3137734,"Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (malignant tumour),,,0.0,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (malignant tumour),,,,0.0
113927,,references out of a total of 58,13999405,[],CHEMBL3137735,"Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,=,1,0,=,,Hepatotoxicity (benign tumour),,,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (benign tumour),,,,0.0
113928,,yes,13999406,[],CHEMBL3137736,Animal toxicity known. [column 'TOXIC' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,,1,0,,,Hepatotoxicity (animal toxicity known),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (animal toxicity known),,,,
113929,,yes,13999407,[],CHEMBL3137737,Presence of at least one case with successful reintroduction. [column 'REINT' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,,1,0,,,Hepatotoxicity (successful reintroduction),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (successful reintroduction),,,,
113930,,AC_ANTI-N,13999408,[],CHEMBL3137738,Comments (NB not yet translated). [column 'COMMENTAIRES' in source],T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,,1,0,,,Hepatotoxicity (comment),,,,CHEMBL612545,,Unchecked,,,,Hepatotoxicity (comment),,,,
113931,,1 day - 10 weeks,13999409,[],CHEMBL3137739,"Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]",T,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,,1,0,,,Hepatotoxicity (time to onset),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (time to onset),,,,
113932,,"Allergic, Dose-dependant",13999410,[],CHEMBL3137740,Proposed mechanism(s) of liver damage. [column 'MEC' in source],T,,,BAO_0000179,BAO_0000221,tissue-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3137667,Gastroenterol Clin Biol,2004.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,1979399,,1,0,,,Hepatotoxicity (mechanism),,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,,Hepatotoxicity (mechanism),,,,
113933,,,14530521,[],CHEMBL3223638,Antimicrobial activity against Staphylococcus aureus ACC 601065 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.6
113934,,,14530524,[],CHEMBL3223639,Antimicrobial activity against Staphylococcus aureus ACC 601065 compound preincubated with 0.1 M hydrochoric acid for 40 mins measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,0.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,0.9
113935,,,14530527,[],CHEMBL3223640,Antimicrobial activity against Streptococcus pyogenes after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.2
113936,,,14530530,[],CHEMBL3223641,Antimicrobial activity against Streptococcus pyogenes compound preincubated with 0.1 M hydrochoric acid for 40 mins measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,0.3,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,0.3
113937,,,14530533,[],CHEMBL3223642,Antimicrobial activity against Haemophilus influenzae ATC 12699 after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,0.6,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,0.6
113938,,,14530536,[],CHEMBL3223643,Antimicrobial activity against Haemophilus influenzae ATC 12699 compound preincubated with 0.1 M hydrochoric acid for 40 mins measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2075960,=,1,1,=,,MIC,ug.mL-1,,1.8,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,1.8
113939,,Not Active,14530541,[],CHEMBL3223646,Antimicrobial activity against Burkholderia cepacia after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2075960,,1,0,,,MIC,,,,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,,,,
113940,,Not Active,14530544,[],CHEMBL3227716,Antimicrobial activity against Burkholderia cepacia compound preincubated with 0.1 M hydrochoric acid for 40 mins measured after 24 hrs by broth microdilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3217711,Medchemcomm,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2075960,,1,0,,,MIC,,,,CHEMBL612499,Burkholderia cepacia,Burkholderia cepacia,292.0,,,MIC,,,,
113941,,,14668826,[],CHEMBL3269283,Antimicrobial activity against Helicobacter pylori isolated from gastrointestinal disease patient after 72 hrs by Etest method,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3259665,Bioorg Med Chem Lett,2014.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2103406,=,1,1,=,,MIC90,ug.mL-1,,8.0,CHEMBL612600,Helicobacter pylori,Helicobacter pylori,210.0,,,MIC90,ug ml-1,UO_0000274,,8.0
113942,,,15171937,[],CHEMBL3405570,"Thermodynamic equilibrium solubility, log S of the compound in water at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,=,1,0,=,,-log(solubility),,,6.17,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,6.17
113943,,,15171989,[],CHEMBL3405571,"Thermodynamic equilibrium solubility, log S of the compound in PBS at pH 7.4 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,=,1,0,=,,-log(solubility),,,6.17,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,6.17
113944,,,15172040,[],CHEMBL3405572,"Thermodynamic equilibrium solubility, log S of the compound in simulated gastric fluid at pH 1.2 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,=,1,0,=,,-log(solubility),,,6.17,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,6.17
113945,,,15172960,[],CHEMBL3405573,"Thermodynamic equilibrium solubility, log S of the compound in simulated intestinal fluid at pH 6.8 at RT after 4 hrs by 96 well plate method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,=,1,0,=,,-log(solubility),,,5.87,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,5.87
113946,,Not Determined,15173011,[],CHEMBL3405574,"Thermodynamic equilibrium solubility, log S of the compound in water at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
113947,,Not Determined,15173062,[],CHEMBL3405575,"Thermodynamic equilibrium solubility, log S of the compound PBS at pH 7.4 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
113948,,Not Determined,15173113,[],CHEMBL3405576,"Thermodynamic equilibrium solubility, log S of the compound simulated gastric fluid at pH 1.2 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
113949,,Not Determined,15173164,[],CHEMBL3405577,"Thermodynamic equilibrium solubility, log S of the compound simulated intestinal fluid at pH 6.8 at RT after 24 hrs by shake-flask method",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,,1,0,,,-log(solubility),,,,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,
113950,,,15174144,[],CHEMBL3405578,"Thermodynamic equilibrium solubility, log S of the compound",P,,,BAO_0000179,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3400005,Bioorg Med Chem Lett,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2285516,=,1,0,=,,-log(solubility),,,7.35,CHEMBL2362975,,No relevant target,,,,-log(solubility),,,,7.35
113951,,,15446791,[],CHEMBL3529279,Transporter substrate index ratio of permeability from apical to basolateral side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Ratio,,,238.0,CHEMBL612558,,ADMET,,,,Ratio,,,,238.0
113952,,,15446851,[],CHEMBL3529278,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Ratio,,,0.8,CHEMBL612558,,ADMET,,,,Ratio,,,,0.8
113953,,,15446911,[],CHEMBL3529277,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Papp,ucm/s,,9.4,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,9.4
113954,,,15446971,[],CHEMBL3529276,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Papp,ucm/s,,11.9,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,11.9
113955,,,15447045,[],CHEMBL3529274,Efflux ratio of permeability from apical to basolateral side over basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0000193,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Ratio,,,5.1,CHEMBL612558,,ADMET,,,,Ratio,,,,5.1
113956,,,15457420,[],CHEMBL3529273,Apparent permeability from basolateral to apical side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Papp,ucm/s,,18.0,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,18.0
113957,,,15458943,[],CHEMBL3529272,Apparent permeability from apical to basolateral side of human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis,A,,,BAO_0002808,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Papp,ucm/s,,3.5,CHEMBL612558,,ADMET,,,,Papp,ucm/s,,,3.5
113958,,,15459005,[],CHEMBL3527758,Fraction absorbed in human,A,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,2471071,=,1,0,=,,Fabs,%,,50.0,CHEMBL372,Homo sapiens,Homo sapiens,9606.0,,,Fabs,%,UO_0000187,,50.0
113959,,,15459520,[],CHEMBL3529441,"Dissociation constant, pKa of the compound",P,,,BAO_0002131,BAO_0000100,small-molecule physicochemical format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526022,Drug Metab Dispos,2013.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2469616,=,1,0,=,,pKa,,,14.1,CHEMBL2362975,,No relevant target,,,,pKa,,,,14.1
113960,,,15464116,[],CHEMBL3529281,Transporter substrate index of efflux ratio in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Ratio,,,85.0,CHEMBL612558,,ADMET,,,,Ratio,,,,85.0
113961,,,15465688,[],CHEMBL3529280,Transporter substrate index ratio of permeability from basolateral to apical side in human Caco2 cells at 10 uM up to 120 mins by HPLC-MC analysis in presence of 1 uM of P-gp inhibitor LY335979,A,,,BAO_0000193,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3526001,Drug Metab Dispos,2011.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2471071,=,1,0,=,,Ratio,,,48.0,CHEMBL612558,,ADMET,,,,Ratio,,,,48.0
113962,,,15466628,[],CHEMBL3537880,Apparent intrinsic clearance in Sprague-Dawley rat hepatocytes assessed per 10'6 cells at 0.1 to 10 uM up to 90 mins by media-loss method,A,,,BAO_0002759,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3525918,Drug Metab Dispos,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2469628,=,1,1,=,,CL,uL.min-1.(10^6cells)-1,,68.0,CHEMBL613289,,Hepatocyte,,,,CLH(app),uL/min/10^6cells,,,68.0
113963,,,15466640,[],CHEMBL3537878,Apparent intrinsic clearance in Sprague-Dawley rat hepatocytes assessed per 10'6 cells at 0.1 to 10 uM up to 90 mins by conventional assay,A,,,BAO_0002759,BAO_0000219,cell-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3525918,Drug Metab Dispos,2012.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2469628,=,1,1,=,,CL,uL.min-1.(10^6cells)-1,,46.0,CHEMBL613289,,Hepatocyte,,,,CLH(app),uL/min/10^6cells,,,46.0
113964,,,15711741,[],CHEMBL3615665,Antimicrobial activity against Streptococcus pyogenes 12-207 expressing mef incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,16.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,16.0
113965,,,15711742,[],CHEMBL3615658,Antimicrobial activity against erythromycin-susceptible Streptococcus pneumoniae ATCC 49619 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,0.062,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,0.062
113966,,,15711756,[],CHEMBL3615659,Antimicrobial activity against Streptococcus pneumoniae 07P390 expressing constitutive ermB incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,64.0
113967,,,15711770,[],CHEMBL3615660,Antimicrobial activity against penicillin-susceptible Streptococcus pneumoniae PU09 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,,MIC,ug ml-1,UO_0000274,,2.0
113968,,,15711784,[],CHEMBL3615661,Antimicrobial activity against Streptococcus pyogenes 01-968 expressing inducible ermA incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MIC,ug ml-1,UO_0000274,,4.0
113969,,,15711798,[],CHEMBL3615662,Antimicrobial activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,32.0
113970,,,15711812,[],CHEMBL3615663,Antimicrobial activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,>,1,1,>,,MIC,ug.mL-1,,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MIC,ug ml-1,UO_0000274,,64.0
113971,,,15711826,[],CHEMBL3615664,Antimicrobial activity against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037 incubated for 20 to 24 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,4.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MIC,ug ml-1,UO_0000274,,4.0
113972,,,15711946,[],CHEMBL3615666,Antimicrobial activity against erythromycin-susceptible Moraxella catarrhalis 11B366 incubated for 20 hrs by two-fold microbroth dilution method,F,,,BAO_0002146,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,1,=,,MIC,ug.mL-1,,0.125,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MIC,ug ml-1,UO_0000274,,0.125
113973,,,15711948,[],CHEMBL3615669,Bactericidal activity against Streptococcus pyogenes 01-968 expressing inducible ermA incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,>,1,0,>,,MBC,ug ml-1,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,8.0
113974,,,15711950,[],CHEMBL3615670,Bactericidal activity against Streptococcus pyogenes 12-207 expressing mef incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,0,=,,MBC,ug ml-1,,32.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,MBC,ug ml-1,UO_0000274,,32.0
113975,,,15711952,[],CHEMBL3615671,Bactericidal activity against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037 incubated for 20 to 24 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,0,=,,MBC,ug ml-1,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,MBC,ug ml-1,UO_0000274,,8.0
113976,,,15711954,[],CHEMBL3615672,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,>,1,0,>,,MBC,ug ml-1,,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,ug ml-1,UO_0000274,,16.0
113977,,Not Determined,15711956,[],CHEMBL3615673,Bactericidal activity against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,,1,0,,,MBC,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,MBC,,,,
113978,,,15711958,[],CHEMBL3615674,Bactericidal activity against erythromycin-susceptible Moraxella catarrhalis 11B366 incubated for 20 hrs followed by sub-culturing for 24 hrs in absence of compound,F,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2498933,=,1,0,=,,MBC,ug ml-1,,0.25,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,MBC,ug ml-1,UO_0000274,,0.25
113979,,,15711960,[],CHEMBL3615792,Ratio of MBC to MIC against Streptococcus pyogenes 01-968 expressing inducible ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,>,1,0,>,,Ratio,,,8.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,,8.0
113980,,,15711962,[],CHEMBL3615793,Ratio of MBC to MIC against Streptococcus pyogenes 12-207 expressing mef,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,=,1,0,=,,Ratio,,,2.0,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,,Ratio,,,,2.0
113981,,,15711964,[],CHEMBL3615794,Ratio of MBC to MIC against azithromycin-susceptible and ampicillin-resistant Haemophilus influenzae 11P037,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,=,1,0,=,,Ratio,,,8.0,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,,Ratio,,,,8.0
113982,,,15711966,[],CHEMBL3615795,Ratio of MBC to MIC against methicillin-resistant Staphylococcus aureus PU32 expressing inducible ermA,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,>,1,0,>,,Ratio,,,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,2.0
113983,,Not Determined,15711968,[],CHEMBL3615796,Ratio of MBC to MIC against methicillin-resistant Staphylococcus aureus PU20 expressing constitutive ermC,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,,1,0,,,Ratio,,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,Ratio,,,,
113984,,,15711970,[],CHEMBL3615797,Ratio of MBC to MIC against erythromycin-susceptible Moraxella catarrhalis 11B366,F,,,BAO_0000193,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3611985,Bioorg Med Chem,2015.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2498933,=,1,0,=,,Ratio,,,2.0,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,,Ratio,,,,2.0
113985,,,16480687,[],CHEMBL3766246,Antibacterial activity against Escherichia coli at 15 ug/ml by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3763119,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Millimeter,2756095,=,1,1,=,,IZ,mm,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,,DIZ,mm,UO_0000016,,16.0
113986,,,16480688,[],CHEMBL3766247,Antibacterial activity against Staphylococcus aureus at 15 ug/ml by disc diffusion method,F,,,BAO_0003039,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3763119,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Millimeter,2756095,=,1,1,=,,IZ,mm,,23.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,,DIZ,mm,UO_0000016,,23.0
113987,,Not Determined,16527387,[],CHEMBL3790269,Antimycobacterial activity against Mycobacterium tuberculosis H37Ra assessed as inhibition of mycobacterial replication after 6 days by microplate Alamar blue assay,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3784999,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2769648,,1,0,,,MIC50,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,,,,
113988,,Not Determined,16527394,[],CHEMBL3790268,Antimycobacterial activity against Mycobacterium bovis BCG assessed as inhibition of mycobacterial replication after 6 days by microplate Alamar blue assay,F,,,BAO_0003035,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3784999,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2769648,,1,0,,,MIC50,,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,,MIC50,,,,
113989,,,16527401,[],CHEMBL3790270,Antimycobacterial activity against Mycobacterium avium ATCC 25291 assessed as inhibition of mycobacterial replication after 6 days by microplate Alamar blue assay,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3784999,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2769648,=,1,1,=,,MIC90,ug.mL-1,,2.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,MIC90,ug ml-1,UO_0000274,,2.0
113990,,,16765222,[],CHEMBL3863121,Growth inhibition of Mycobacterium avium ATCC 25291 at 2 ug/ml after 6 days by microplate alamar blue assay,F,,,BAO_0000096,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3861999,Bioorg Med Chem,2016.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://qudt.org/vocab/unit#Percent,2802966,=,1,0,=,,GI,%,,100.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,,GI,%,UO_0000187,,100.0
113991,,,16803063,[],CHEMBL3869446,Antibacterial activity against Propionibacterium acnes ATCC 6919 after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3868600,Bioorg Med Chem,2017.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809154,=,1,1,=,,MIC90,ug.mL-1,,0.5,CHEMBL612639,Cutibacterium acnes,Cutibacterium acnes,1747.0,,,MIC90,ug ml-1,UO_0000274,,0.5
113992,,,16803070,[],CHEMBL3869447,Antibacterial activity against Streptococcus mitis NCIMB 13770 after 24 hrs by broth microdilution method,F,,,BAO_0000179,BAO_0000019,assay format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3868600,Bioorg Med Chem,2017.0,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2809154,=,1,1,=,,MIC90,ug.mL-1,,0.25,CHEMBL614952,Streptococcus mitis,Streptococcus mitis,28037.0,,,MIC90,ug ml-1,UO_0000274,,0.25
113993,,See Activity_Supp For Individual Animal Data,17382524,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ALT (Alanine Aminotransferase)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'ALT (Alanine Aminotransferase)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2834816,=,15,1,=,,ALT,U.L-1,,60.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,ALANINE AMINOTRANSFERASE,u/L,,,60.33
113994,,See Activity_Supp For Individual Animal Data,17382527,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ALB (Albumin)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'ALB (Albumin)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834816,=,15,1,=,,ALB,ug.mL-1,,40000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,ALBUMIN,G/DL,UO_0000274,,4.0
113995,,See Activity_Supp For Individual Animal Data,17382530,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ALP (Alkaline Phosphatase)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'ALP (Alkaline Phosphatase)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2834816,=,15,1,=,,ALP,U.L-1,,334.83,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,ALKALINE PHOSPHATASE,u/L,,,334.83
113996,,See Activity_Supp For Individual Animal Data,17382533,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'AST (Aspartate Aminotransferase)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'AST (Aspartate Aminotransferase)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2834816,=,15,1,=,,AST,U.L-1,,74.5,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,ASPARTATE AMINOTRANSFERASE,u/L,,,74.5
113997,,See Activity_Supp For Individual Animal Data,17382536,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'BUN (Blood Urea Nitrogen)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'BUN (Blood Urea Nitrogen)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2834816,=,15,1,=,,BUN,ug.mL-1,,135.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,BLOOD UREA NITROGEN,mg/dL,UO_0000274,,13.5
113998,,See Activity_Supp For Individual Animal Data,17382539,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'CO2 (Carbon Dioxide)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'CO2 (Carbon Dioxide)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,http://www.openphacts.org/units/Nanomolar,2834816,=,15,1,=,,CO2,nM,,30330000.0,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,CARBON DIOXIDE,MMOL/L,UO_0000065,,30.33
113999,,See Activity_Supp For Individual Animal Data,17382542,"[{'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'CHLORIDE (Chloride)', 'standard_type': 'ACTIVITY_TEST', 'standard_units': None, 'standard_value': None, 'text_value': 'CHLORIDE (Chloride)', 'type': 'ACTIVITY_TEST', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Biochemistry', 'standard_type': 'DATASET', 'standard_units': None, 'standard_value': None, 'text_value': 'Biochemistry', 'type': 'DATASET', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'DOSE', 'standard_units': 'mg.kg-1', 'standard_value': '0.0', 'text_value': None, 'type': 'DOSE', 'units': 'mg/Kg', 'value': '0.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Control', 'standard_type': 'DOSE_LEVEL', 'standard_units': None, 'standard_value': None, 'text_value': 'Control', 'type': 'DOSE_LEVEL', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'N_ANIMALS', 'standard_units': None, 'standard_value': '6.0', 'text_value': None, 'type': 'N_ANIMALS', 'units': None, 'value': '6.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'ORAL GAVAGE', 'standard_type': 'ROUTE', 'standard_units': None, 'standard_value': None, 'text_value': 'ORAL GAVAGE', 'type': 'ROUTE', 'units': None, 'value': None}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'SRC_ACTIVITY_ID', 'standard_units': None, 'standard_value': '242.0', 'text_value': None, 'type': 'SRC_ACTIVITY_ID', 'units': None, 'value': '242.0'}, {'comments': None, 'relation': '=', 'result_flag': 0, 'standard_relation': '=', 'standard_text_value': None, 'standard_type': 'TIME', 'standard_units': 'hr', 'standard_value': '72.0', 'text_value': None, 'type': 'TIME', 'units': 'day', 'value': '3.0'}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'Plasma', 'standard_type': 'TISSUE', 'standard_units': None, 'standard_value': None, 'text_value': 'Plasma', 'type': 'TISSUE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '20011204', 'standard_type': 'TOXICOLOGY_STUDY_DATE', 'standard_units': None, 'standard_value': None, 'text_value': '20011204', 'type': 'TOXICOLOGY_STUDY_DATE', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'S011204', 'standard_type': 'TOXICOLOGY_STUDY_ID', 'standard_units': None, 'standard_value': None, 'text_value': 'S011204', 'type': 'TOXICOLOGY_STUDY_ID', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': 'SRI International', 'standard_type': 'TOXICOLOGY_STUDY_LAB', 'standard_units': None, 'standard_value': None, 'text_value': 'SRI International', 'type': 'TOXICOLOGY_STUDY_LAB', 'units': None, 'value': None}, {'comments': None, 'relation': None, 'result_flag': 0, 'standard_relation': None, 'standard_text_value': '100 % WATER', 'standard_type': 'VEHICLE', 'standard_units': None, 'standard_value': None, 'text_value': '100 % WATER', 'type': 'VEHICLE', 'units': None, 'value': None}]",CHEMBL3885882,DrugMatrix - Regimen: Daily Repeat,T,,,BAO_0000179,BAO_0000218,organism-based format,CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O,,,CHEMBL3885881,,,,CHEMBL1741,CLARITHROMYCIN,CHEMBL1741,,0,,2834816,=,15,1,=,,CHLORIDE,mEq.L-1,,98.33,CHEMBL376,Rattus norvegicus,Rattus norvegicus,10116.0,,10909.0,CHLORIDE,MEQ/L,,,98.33
